USRE42959E1 - Apparatus and methods for stimulating revascularization and/or tissue growth - Google Patents
Apparatus and methods for stimulating revascularization and/or tissue growth Download PDFInfo
- Publication number
- USRE42959E1 USRE42959E1 US10/246,030 US24603002A USRE42959E US RE42959 E1 USRE42959 E1 US RE42959E1 US 24603002 A US24603002 A US 24603002A US RE42959 E USRE42959 E US RE42959E
- Authority
- US
- United States
- Prior art keywords
- catheter
- bioactive agent
- region
- needle
- cardiac tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00026—Conductivity or impedance, e.g. of tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00106—Sensing or detecting at the treatment site ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00367—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like
- A61B2017/00398—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like using powered actuators, e.g. stepper motors, solenoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/00196—Moving parts reciprocating lengthwise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/00202—Moving parts rotating
- A61B2018/00208—Moving parts rotating actively driven, e.g. by a motor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00291—Anchoring means for temporary attachment of a device to tissue using suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00738—Depth, e.g. depth of ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00761—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/0091—Handpieces of the surgical instrument or device
- A61B2018/00916—Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
- A61B2018/1437—Spiral whereby the windings of the spiral touch each other such as to create a continuous surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
- A61B2018/1861—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves with an instrument inserted into a body lumen or cavity, e.g. a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/007—Aspiration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
Definitions
- the present invention relates to apparatus and methods for stimulating revascularization and tissue growth in an interior region of an organ or vessel, such as the heart. More particularly, the present invention provides a device that enables a clinician to stimulate a healing response, or deposit a bioactive agent at, a series of sites within in interior region of an organ or vessel to stimulate revascularization.
- a leading cause of death in the United States today is coronary artery disease, in which atherosclerotic plaque causes blockages in the coronary arteries, resulting in ischemia of the heart (i.e., inadequate blood flow to the myocardium).
- the disease manifests itself as chest pain or angina.
- approximately 7 million people suffered from angina in the United States In 1996, approximately 7 million people suffered from angina in the United States.
- Coronary artery bypass grafting in which the patient's chest is surgically opened and an obstructed artery replaced with a native artery harvested elsewhere, has been the conventional treatment for coronary artery disease for the last thirty years. Such surgery creates significant trauma to the patient, requires long recuperation times, and causes a great deal of morbidity and mortality. In addition, experience has shown that the graft becomes obstructed with time, requiring further surgery.
- PTCA percutaneous transluminal coronary angioplasty
- atherectomy involves using an end effector, such as a mechanical cutting device (or laser) to cut (or ablate) a passage through the blockage.
- an end effector such as a mechanical cutting device (or laser) to cut (or ablate) a passage through the blockage.
- Such methods have drawbacks, however, ranging from re-blockage of dilated vessels with angioplasty to catastrophic rupture or dissection of the vessel during atherectomy.
- these methods may only be used for that fraction of the patient population where the blockages are few and are easily accessible. Neither technique is suitable for the treatment of diffuse atherosclerosis.
- transmyocardial revascularization a series of channels are formed in the left ventricular wall of the heart. Typically, between 15 and 30 channels about 1 mm in diameter and up to 3.0 cm deep are formed with a laser in the wall of the left ventricle to perfuse the heart muscle with blood coming directly from the inside of the left ventricle, rather than traveling through the coronary arteries. Some researchers believe that the resulting channels improve perfusion of the myocardium with oxygenated blood. Apparatus and methods have been proposed to create such channels both percutaneously and intraoperatively (i e., with the chest opened).
- U.S. Pat. No. 5,389,096 to Aita et al. describes a catheter-based laser apparatus for use in percutaneously forming channels extending from the endocardium into the myocardium.
- the catheter includes a plurality of control lines for directing the tip of the catheter.
- the laser ablates the tissue during the channel forming process, the surrounding tissue necroses, resulting in fibroid scar tissue surrounding the channels.
- U.S. Pat. No. 5,380,316 to Aita et al. describes an intraoperative laser-based system for performing TMR.
- U.S. Pat. No. 5,591,159 to Taheri describes mechanical apparatus for performing TMR comprising a catheter having an end effector formed from a plurality of spring-loaded needles.
- the catheter first is positioned percutaneously Within the left ventricle.
- a plunger is then released so that the needles are thrust into the endocardium.
- the needles core out small channels that extend into the myocardium as they are withdrawn.
- the patent suggests that the needles may he withdrawn and advanced repetitively at different locations under fluoroscopic guidance. The patent does not appear to address how tissue is ejected from the needles between the tissue-cutting steps
- TMR channels remain patent for long periods of time, and provide a path by which oxygenated blood perfuses the myocardium.
- relatively recent histological studies indicate that TMR channels may close within a short time following the procedure. For example, Fleischer et al., in “One-Month Histologic Response Of Transmyocardial Laser Channels With Molecular Intervention,” Ann. Soc. Thoracic Surg., 62:1051-58 (1996), evaluated histologic changes associated with laser TMR in a 1-month nonischemic porcine model, and was unable to demonstrate channel patency 28 days after TMR.
- VEGF vascular endothelial growth factor
- a bioactive agent such as an angiogenic growth factor
- a bioactive agent such as a drug or an angiogenic growth factor
- the apparatus may optionally include electrodes for depositing RF energy to form a controlled degree of scar tissue formation, means for depositing a controlled amount of a bioactive agent at the treatment site, or both.
- Apparatus constructed in accordance with the present invention comprises a catheter having a longitudinal axis, an end region that is deflectable relative to the longitudinal axis, and a tissue piercing end effector.
- the end effector may optionally include an RF electrode for causing a controlled degree of necrosis at a treatment site, the capability to deposit a controlled amount of a bioactive agent at the treatment site, or both.
- Methods of using the apparatus of the present invention to stimulate revascularization and/or tissue growth are also provided.
- FIG. 1 is a view of an illustrative embodiment of apparatus constructed in accordance with the present invention
- FIG. 2 is a perspective view of an end region and end effector of the apparatus of FIG. 1 ;
- FIG. 3 is schematic view of an illustrative arrangement for driving the end effector of FIG. 1 ;
- FIG. 4 is a partial side view of the end effector of the apparatus of FIG. 1 ;
- FIG. 5 is a schematic view of an alternative illustrative arrangement for driving an end effector adapted to deliver a bioactive agent
- FIG. 6 is a partial side view of the end effector of the apparatus of FIG. 5 ;
- FIGS. 7A to 7C are views illustrating operation of the apparatus of FIG. 1 .
- FIG. 8 is a schematic view of another alternative arrangement for driving the end effector of the apparatus of FIG. 1 ;
- FIG. 9 is a schematic view of a yet another further alternative arrangement for driving an end effector constructed in accordance with the present invention.
- FIGS. 10A and 10B are, respectively, partial side sectional views illustrating operation of another end effector of the present invention.
- FIGS. 11A and 11B are, respectively, a partial side sectional view and cross-sectional view of a further alternative embodiment of an end effector of the present invention.
- FIGS. 12A to 12D are views illustrating operation of the end effector of FIGS. 11 to deposit a pellet of a bioactive agent at a treatment site.
- the present invention relates generally to apparatus and methods for treating a plurality of tissue sites within a vessel or organ to stimulate tissue growth and revascularization.
- the apparatus of the present invention comprises a catheter having an end region that may be selectively articulated to a position at an angle relative to the longitudinal axis of the catheter, including a position substantially orthogonal to the longitudinal axis.
- the end region carries a tissue piercing end effector to induce trauma to stimulate native tissue repair and revascularization mechanisms.
- the end effector may optionally include an RF electrode to cause a controlled degree of necrosis, means for depositing a controlled amount of a bioactive agent at the treatment site, or both.
- the deflectable end region of the catheter provides precise control over the location of the end region, and thus, the end effector.
- Apparatus 20 comprises catheter 21 having deflectable end region 22 , end effector 23 and handle 24 , cable 25 and controller 26 .
- Apparatus 20 is coupled via cable 25 to controller 26 .
- End effector 23 described in greater detail hereinbelow, pierces myocardial tissue, with or without coring, to attain a treatment goal.
- End region 22 includes one or more control wires 27 disposed for sliding movement within catheter 21 , such as described in U.S. Pat. Nos. 5,389,073 and 5,330,466 to Imran, which are incorporated herein by reference.
- Application of a predetermined proximal force on control wire 27 (indicated by arrow A), deflects end region 23 a predetermined amount (shown in dotted lines in FIG. 2 ). Accordingly, end region 23 may be moved between a transit position, parallel to longitudinal axis 28 of catheter 21 and a working position (as shown) substantially orthogonal to longitudinal axis 28 .
- controller 26 includes a hydraulic or pneumatic piston, valve assembly and control logic for extending and retracting the end effector beyond the distal endface of end region 23 responsive to commands input at handle assembly 24 or a footpedal (not shown)
- Controller 26 optionally may further contain RF generator circuitry for energizing electrodes disposed on the end effector to cause a controlled degree of necrosis at the treatment site.
- controller 26 may include a source of a bioactive agent, and means for delivering controlled amounts of the bioactive agent to the treatment site.
- End effector 23 comprises tissue piercing cone 41 having optional first and second RF electrodes 42 a and 42 b, respectively.
- End effector preferably comprises a rigid material that retains a sharp tip, such as stainless steel Drive shaft 43 , which extends through cable 25 of FIG. 1 , is coupled to end effector 23 via flexible coupling 44 at its distal end, and to piston 45 at its proximal end.
- Drive shaft 43 is disposed for reciprocation in end region 22 responsive to movement of piston 45 .
- Drive shaft 43 may comprise a single or braided plastic or metal alloy wire, while flexible coupling 44 comprises a sturdy but flexible plastic or metal alloy.
- Piston 45 is enclosed within cylinder 46 for proximal and distal movement.
- High pressure source 47 is connected to valve 48 and pressure lines 49 a and 49 b; low pressure source 50 is connected to valve 51 and pressure lines 52 a and 52 b.
- Pressure lines 49 a and 52 a communicate with proximal volume 53 a of cylinder 46
- pressure lines 49 b and 52 b communicate with distal volume 53 b of cylinder 46 .
- Valves 48 and 51 are synchronized so that when high pressure source 47 is coupled to pressure line 49 a (but not 49 b), low pressure source 50 is coupled to line 52 b (but not 52 a), thus driving piston 45 in the distal direction.
- valve 48 couples high pressure source 47 to pressure line 49 b (but not 49 a)
- valve 51 couples low pressure source 50 to line 52 a (but not 52 b)
- piston 45 is driven in the proximal direction.
- Valves 48 and 51 are coupled by wiring (not shown) to control logic 54 , which actuates the valves responsive to control commands received from handle assembly 26 or a footpedal (not shown).
- Cylinder 46 may employ any suitable medium for moving piston 45 , and may be either pneumatic or hydraulic.
- Controller 26 optionally includes RF generator circuitry 55 which generates a high frequency (e.g., greater than 100 MHZ) voltage signal.
- RF generator circuitry 55 is coupled via suitable bushings and conductors (not shown) to electrodes 42 a and 42 b. Electrodes 42 a and 42 b may be arranged to conduct current through tissue located in contact them, in a bipolar mode, or may conduct current through the tissue and to a ground plate (not shown) in a monopolar mode.
- control logic 54 may be programmed to energize electrodes 42 a and 42 b when piston 45 has attained its maximum distal stroke. Control logic 54 may energize electrodes 42 a and 42 b for a user selected interval to provide a controlled degree of necrosis in the tissue surrounding the treatment site created by end effector 23 .
- end effector 23 when piston 45 is driven in the distal direction, end effector 23 extends beyond the distal endface of catheter 21 and pierces and extends into tissue T. End effector 23 thereby induces trauma to tissue T in the form of needle track N. If electrodes 42 a and 42 b and RF generator circuitry 55 are provided, control logic 55 may energize the electrodes to cause necrosis of tissue T in a region R surrounding the end effector. Control logic 54 then reverses the orientation of valves 48 and 51 , thus causing end effector 23 to be retracted from tissue T and into end region 22 .
- End effector 60 comprises non-coring tissue piercing cone 61 affixed to drive shaft 62 .
- Drive shaft 62 includes lumen 63 , and extends through cable 25 of FIG. 1
- Drive shaft 62 is coupled to piston 64 at its proximal end, and is disposed for reciprocation in the guide tube (not shown) responsive to movement of piston 64 .
- Drive shaft 62 preferably comprises a thin-walled but flexible plastic or metal alloy tube.
- End effector 60 may optionally include electrodes 65 a and 65 b for applying an RF voltage potential to the tissue to cause a controlled degree of necrosis, as described hereinabove with respect to the embodiment of FIGS. 3 and 4 .
- Piston 64 is enclosed within a cylinder in controller 66 for proximal and distal movement.
- High pressure source 67 is connected to valve 68 and pressure lines 69 a and 69 b; low pressure source 70 is connected to valve 71 and pressure lines 72 a and 72 b.
- Pressure lines 69 a and 72 a communicate with proximal volume 73 a of the cylinder, whereas pressure lines 69 b and 72 b communicate with distal volume 73 b of the cylinder
- Valves 68 and 71 are synchronized as described hereinabove with respect to like components of FIG. 4 , so as to extend and retract end effector 60 under the control of control logic 74 responsive to control commands received from handle assembly 26 .
- Drive shaft 62 includes a plurality of outlet ports 75 located adjacent to cone 61 and a plurality of inlet ports 76 disposed in chamber 77 .
- Chamber 77 contains bioactive agent 80 suspended in a biocompatible high viscosity liquid or paste, and is selectively pressurized by pressure source 78 .
- Bioactive agent 80 may comprise a drug or an angiogenic growth factor, for example, vascular endothelial growth factor (VEGF), fibroblast growth factor, type I (FGF-I) or type II (FGF-II), a gene vector, cardio myocytes, or other suitable agent for stimulating tissue growth and/or revascularization.
- VEGF vascular endothelial growth factor
- FGF-I fibroblast growth factor
- FGF-III type II
- cardio myocytes or other suitable agent for stimulating tissue growth and/or revascularization.
- a controlled amount of bioactive agent 80 is injected into inlet ports 76 of lumen 63 . This in turn causes an equal amount of bioactive agent 80 to be expelled through outlet ports 75 of end effector 60 into the adjacent tissue.
- Control logic 74 preferably is programmed to actuate high pressure source 78 when piston 64 has attained its maximum distal stroke.
- Controller 66 may in addition include an RF generator circuitry similar to RF generator circuitry 55 of the embodiment of FIG. 3 for energizing electrodes 65 a and 65 b.
- end effector 60 when piston 64 is driven in the distal direction, end effector 60 extends beyond the distal endface of the catheter and pierces and extends into tissue T. End effector 60 thereby causes trauma to tissue T in the form of needle track N. Once end effector 60 reaches its maximum depth, control logic 74 actuates high pressure source 78 , causing a controlled amount of bioactive agent 80 to be expelled through outlet ports 75 into the tissue.
- control logic 74 reverses the orientation of valves 68 and 71 , thus causing end effector 60 to be retracted from tissue T and into the end region of the catheter. If provided, RF electrodes 65 a and 65 b may be activated to cauterize tissue in the vicinity of needle track N.
- FIGS. 7A–7C operation of apparatus 20 in the context of treating a series of treatment sites to stimulate revascularization in left ventricular myocardium is described.
- end region 22 of apparatus 20 is shown positioned in a patient's left ventricular cavity, using techniques which are per se known. Specifically, end region 22 of apparatus 20 is inserted via a femoral artery, and is maneuvered under fluoroscopic guidance in a retrograde manner up through the descending aorta, through aortic arch 201 , and down through ascending aorta 202 and aortic valve 203 into left ventricle 204 . As will of course be understood, insertion of apparatus 20 into the left ventricle is with end region 22 in its transit position.
- Previously known imaging techniques such as ultrasound, MRI scan, CT scan, or fluoroscopy, may be used to verify the location of the end region 22 within the heart.
- means may be provided in end region 22 for emitting an ultrasonic signal which is detectable using an ultrasound imaging system outside of the patient.
- a piezo-electric transducer may be affixed to the tip of the catheter and tuned to a frequency of a color Doppler ultrasound imaging system so as to appear as a bright orange or yellow spot on the display of the ultrasound system.
- Yet another way to detect the location of end region 22 is by pinpointing the delay time of an EKG signal at the point of detection, using an electrode disposed in end region 22 . By looking at the morphology as well as the temporal characteristics of the EKG signal, the vertical position of the catheter within the heart chamber may be determined.
- end region 22 is deflected to its working position, for example, by operating control wire 27 . In this manner end effector 23 is disposed against a surface of the endocardium to be treated.
- Controller 26 is then actuated to cause end effector 23 to pierce and extend into the interior of left ventricular wall 206 .
- a burst of RF energy may be applied, if desired, to necrose a depth of tissue, an amount of a bioactive agent may be deposited at the treatment site, or both. Controller 26 then withdraws end effector 23 from the tissue.
- a series of vertically aligned spaced-apart needle tracks 207 may he formed in left ventricular wall 206 by repositioning end region 22 using control wire 27 . End effector 23 is then advanced to form a further needle track 207 in the tissue.
- the foregoing methods enable a matrix of channels to be formed illustratively in the left ventricular wall. It will of course be understood that the same steps may be performed in mirror image to produce a series of needle tracks in the septal region. It is believed that the needle tracks may have a beneficial effect if formed anywhere on the walls of the heart chamber, including the septum, apex and left ventricular wall; the above-described apparatus provides this capability
- a stabilization assembly may be employed, for example, as described in copending, commonly assigned U.S. patent application Ser. No. 08/863,877, filed May 27, 1997, to counteract any reaction forces generated by operation of end effector 23 .
- FIG. 8 an alternative arrangement for driving the end effector of the present invention is described.
- controller 130 of FIG. 8 the piston and cylinder of controller 26 of FIG. 1 are replaced with a mechanical drive system.
- End effector 131 comprises non-coring sharpened tip 132 coupled to drive shaft 133 .
- Drive shaft 133 is coupled at its proximal end to push rod 134 .
- Push rod 134 is biased against eccentric cam 135 by spring 136 .
- Cam 135 is mounted on motor 137 , which rotates cam 135 through one revolution responsive to commands from control logic 138 .
- Control logic 138 actuates motor 137 responsive to commands received, for example, by a button on handle 24 (see FIG. 1 ).
- controller 130 extends and retracts end effector 131 to create a needle track in the tissue.
- controller 130 may optionally include either the RF generator circuitry and electrodes of the embodiment of FIG. 3 , the bioactive agent delivery system described with respect to the embodiment of FIG. 5 , or both.
- the specific drive arrangements described hereinabove are intended to be illustrative, and other mechanisms may be readily employed.
- the specific configuration of the pressure sources, pressure lines and the valves in FIGS. 3 and 5 are intended to be merely illustrative.
- Equivalent mechanisms for extending and retracting the end effector may be readily employed within the scope of the present invention.
- the end effector may be spring loaded so as to be biased in the extended position and reset after having been extended to form each needle track.
- end effector 142 comprises tip 143 having aperture 144 coupled to the distal end of drive shaft 145 .
- Proximal end 146 of drive shaft 145 includes actuator ring 147
- proximal end 148 of catheter 141 includes rings 149 .
- drive shaft 144 may be driven in the distal direction to extend end effector 142 by squeezing actuator ring 147 towards rings 149 .
- drive shaft 145 includes lumen 150 and push wire 151 disposed within lumen 150 .
- Push wire 151 terminates at its proximal end in a plurality of fine wires 152 .
- Wires 152 may comprise, for example, nickel-titanium, and are constructed so that when they extend through aperture 144 , the wires diverge (see FIG. 10B ).
- Push wire 151 extends through lumen 150 of drive shaft 145 and terminates in button 153 .
- button 153 may be depressed toward flange 154 , thereby extending wires 152 through aperture 144 .
- FIG. 10A shows end effector 142 extended to pierce and extend into tissue T to form needle track N, for example, by squeezing actuator ring 147 towards ring 149 .
- this step occurs after the catheter has been disposed within an organ or vessel as described above with respect to FIGS. 7A and 7B .
- FIG. 10B illustrates that extension and retraction of wires 152 generates a matrix of additional needle tracks N′ Applicant expects that, like the application of RF energy to form a controlled layer of scar tissue, or the deposition of an amount of a bioactive agent, the matrix of needle tracks N′ will further stimulate revascularization in the tissue
- End effector 160 comprises tube 161 including beveled non-coring tip 162 mounted in distal end 163 of catheter 164 .
- Push rod 165 is disposed for reciprocation in lumen 166 of tube 161 .
- catheter 164 includes lumen 167 in which tube 161 is disposed, and lumen 168 through which bioactive pellets 170 , illustratively, spherical beads, are advanced to end effector 160 .
- Lumen 168 includes passageway 169 through which a pellet passes to engage push rod 165 for delivery.
- pellets 170 comprise a bioactive agent, as described hereinabove, disposed in a biodegradable binder, such as polycaprolactone or polylactic acid.
- Pellets 170 are sized to advance through lumen 168 freely and without bunching, so that when posh rod is retracted in the proximal direction past the proximal edge of passageway 169 , a single pellet 170 passes into lumen 166 of tube 161 .
- pellets 170 are illustrative spherical, it is to be understood that the bioactive agent may be readily formed into any of a number of other shapes, such as rods, cones, granules, etc., and that the above-described delivery system may be readily adapted to such other pelletized forms.
- Apparatus including end effector 160 first is disposed within an internal organ, such as the left ventricle, as described hereinabove with respect to FIGS. 7A to 7C .
- End effector 160 then is oriented so as to be positioned at a desired angle, e.g. perpendicular, to tissue T to be treated.
- posh rod 165 is extended so that distal endface 171 extends past the distal edge of passageway 169 , thereby confining pellets 170 within lumen 168 .
- End effector 160 is urged in the distal direction to form needle track N, and so that tip 162 penetrates tissue T until catheter 164 abuts against the endocardium (shown in FIG. 12A ).
- Push rod 165 then is retracted in the proximal direction, so that distal endface 171 is positioned proximally of the proximal edge of passageway 169 .
- pellets 170 are preferably only slightly smaller than the diameter of lumen 166 , when a single pellet 170 has advanced into lumen 166 , it will block other pellets from passing through passageway 169 into lumen 166 .
- pellets 170 may be sized so that a predetermined number of pellets pass into lumen 166 each time push rod 165 is retracted proximally.
- Push rod 165 then is driven in the distal direction, urging pellet 170 to the end of needle track N, as illustrated in FIG. 12C
- RF electrodes are provided on tip 162 , such electrodes may be energized to necrose a predetermined thickness of tissue in the vicinity of tip 162 .
- End effector 160 then is withdrawn, leaving pellet 170 within needle track N in tissue T.
- pellet 170 preferably comprises a biodegradable substance that elutes a suitable bioactive agent into the tissue surrounding the pellet over a preselected period of time. It is expected that by depositing a bioactive substance within tissue T, tissue revascularization and growth may be stimulated, as described hereinabove. End effector 160 then is moved to another location and the foregoing process repeated to seed a plurality of pellets 170 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Apparatus and methods for stimulating revascularization and tissue growth are provided using an apparatus having a directable end region carrying a tissue piercing end effector. The apparatus optionally includes electrodes for depositing RF energy to form a controlled degree of scar tissue formation, means for delivering a controlled amount of a bioactive agent at the treatment site, or both.
Description
The present application is a continuation-in-part application of commonly assigned U.S. patent application Ser. No. 08/863,791, now U.S. Pat. No. 5,931,848, Ser. No. 08/863,877, now U.S. Pat. No. 5,910,150, and Ser. No. 08/863,925, now U.S. Pat. No. 5,941,839, all filed May 27, 1997.The present application is a continuation-in-part application of commonly assigned U.S. patent application Ser. No. 08/863,791, now U.S. Pat. No. 5,931,848, and Ser. No. 08/863,877, now U.S. Pat. No. 5,910,150, and Ser. No. 08/863,925, now U.S. Pat. No. 5,941,893, all filed May 27, 1997, all of which claim the benefit of the filing date of U.S. provisional patent application Ser. No. 60/032,196, filed Dec. 2, 1996.
The present invention relates to apparatus and methods for stimulating revascularization and tissue growth in an interior region of an organ or vessel, such as the heart. More particularly, the present invention provides a device that enables a clinician to stimulate a healing response, or deposit a bioactive agent at, a series of sites within in interior region of an organ or vessel to stimulate revascularization.
A leading cause of death in the United States today is coronary artery disease, in which atherosclerotic plaque causes blockages in the coronary arteries, resulting in ischemia of the heart (i.e., inadequate blood flow to the myocardium). The disease manifests itself as chest pain or angina. In 1996, approximately 7 million people suffered from angina in the United States.
Coronary artery bypass grafting (CABG), in which the patient's chest is surgically opened and an obstructed artery replaced with a native artery harvested elsewhere, has been the conventional treatment for coronary artery disease for the last thirty years. Such surgery creates significant trauma to the patient, requires long recuperation times, and causes a great deal of morbidity and mortality. In addition, experience has shown that the graft becomes obstructed with time, requiring further surgery.
More recently, catheter-based therapies such as percutaneous transluminal coronary angioplasty (PTCA) and atherectomy have been developed. In PTCA, a mechanical dilatation device is disposed across an obstruction in the patient's artery and then dilated to compress the plaque lining the artery to restore patency to the vessel. Atherectomy involves using an end effector, such as a mechanical cutting device (or laser) to cut (or ablate) a passage through the blockage. Such methods have drawbacks, however, ranging from re-blockage of dilated vessels with angioplasty to catastrophic rupture or dissection of the vessel during atherectomy. Moreover, these methods may only be used for that fraction of the patient population where the blockages are few and are easily accessible. Neither technique is suitable for the treatment of diffuse atherosclerosis.
A more recent technique which holds promise for treating a larger percentage of the patient population, including those patients suffering from diffuse atherosclerosis, is referred to as transmyocardial revascularization (TMR). In this method, a series of channels are formed in the left ventricular wall of the heart. Typically, between 15 and 30 channels about 1 mm in diameter and up to 3.0 cm deep are formed with a laser in the wall of the left ventricle to perfuse the heart muscle with blood coming directly from the inside of the left ventricle, rather than traveling through the coronary arteries. Some researchers believe that the resulting channels improve perfusion of the myocardium with oxygenated blood. Apparatus and methods have been proposed to create such channels both percutaneously and intraoperatively (i e., with the chest opened).
U.S. Pat. No. 5,389,096 to Aita et al. describes a catheter-based laser apparatus for use in percutaneously forming channels extending from the endocardium into the myocardium. The catheter includes a plurality of control lines for directing the tip of the catheter. As the laser ablates the tissue during the channel forming process, the surrounding tissue necroses, resulting in fibroid scar tissue surrounding the channels. U.S. Pat. No. 5,380,316 to Aita et al. describes an intraoperative laser-based system for performing TMR.
U.S. Pat. No. 5,591,159 to Taheri describes mechanical apparatus for performing TMR comprising a catheter having an end effector formed from a plurality of spring-loaded needles. The catheter first is positioned percutaneously Within the left ventricle. A plunger is then released so that the needles are thrust into the endocardium. The needles core out small channels that extend into the myocardium as they are withdrawn. The patent suggests that the needles may he withdrawn and advanced repetitively at different locations under fluoroscopic guidance. The patent does not appear to address how tissue is ejected from the needles between the tissue-cutting steps
Although it is generally agreed that TMR benefits many patients, researchers do not agree upon the precise mechanism by which TMR provides therapeutic benefits. One theory proposes that TMR channels remain patent for long periods of time, and provide a path by which oxygenated blood perfuses the myocardium. However, relatively recent histological studies indicate that TMR channels may close within a short time following the procedure. For example, Fleischer et al., in “One-Month Histologic Response Of Transmyocardial Laser Channels With Molecular Intervention,” Ann. Soc. Thoracic Surg., 62:1051-58 (1996), evaluated histologic changes associated with laser TMR in a 1-month nonischemic porcine model, and was unable to demonstrate channel patency 28 days after TMR.
Other researchers have observed that in laser-based TMR patients, there appears to he enhanced vascularization of the tissue on the margins of the scar tissue resulting from the laser channel-forming process. It has therefore been hypothesized that the act of causing trauma to portions of the myocardium may invoke a regenerative process, that enhances the development of neovascularization and endothelialization in the tissue.
To investigate these alternative theories, researchers have studied the use of gene therapy in promoting blood vessel growth in the tissue surrounding laser TMR channels. In one study, researchers intraoperatively administered a single dose of vascular endothelial growth factor (VEGF) at the time of laser TMR. Although the study showed no significant increase in myocardial vascularity, the researchers hypothesized that a longer duration of VEGF residence may be necessary to stimulate angiogenesis.
In view of the foregoing, it would be desirable to provide apparatus and methods for stimulating revascularization and tissue growth in an interior region of an organ or vessel, such as the heart, by stimulating native revascularization and tissue growth mechanisms.
It would also be desirable to provide apparatus and methods for stimulating revascularization and tissue growth by controlling the placement and size of tissue treatment sites, thereby resulting in a controlled degree of scar tissue formation.
It would be still further desirable to provide apparatus and methods for stimulating revascularization and tissue growth by depositing a controlled amount of a bioactive agent, such as an angiogenic growth factor, at the treatment sites.
In view of the foregoing, it is an object of this invention to provide apparatus and methods for stimulating revascularization and tissue growth in an interior region of an organ or vessel, such as the heart, by stimulating native revascularization and tissue growth mechanisms.
It is another object of the present invention to provide apparatus and methods for stimulating revascularization and tissue growth by controlling the placement and size of tissue treatment sites, thereby resulting in a controlled degree of scar tissue formation.
It is a still further object of this invention to provide apparatus and methods for stimulating revascularization and tissue growth by depositing a controlled amount of a bioactive agent, such as a drug or an angiogenic growth factor, at the treatment sites.
These and other objects of the present invention are accomplished by providing apparatus having a directable end region carrying an end effector that induces trauma at a treatment site to stimulate revascularization. The apparatus may optionally include electrodes for depositing RF energy to form a controlled degree of scar tissue formation, means for depositing a controlled amount of a bioactive agent at the treatment site, or both.
Apparatus constructed in accordance with the present invention comprises a catheter having a longitudinal axis, an end region that is deflectable relative to the longitudinal axis, and a tissue piercing end effector. The end effector may optionally include an RF electrode for causing a controlled degree of necrosis at a treatment site, the capability to deposit a controlled amount of a bioactive agent at the treatment site, or both.
Methods of using the apparatus of the present invention to stimulate revascularization and/or tissue growth are also provided.
Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
The present invention relates generally to apparatus and methods for treating a plurality of tissue sites within a vessel or organ to stimulate tissue growth and revascularization. The apparatus of the present invention comprises a catheter having an end region that may be selectively articulated to a position at an angle relative to the longitudinal axis of the catheter, including a position substantially orthogonal to the longitudinal axis.
The end region carries a tissue piercing end effector to induce trauma to stimulate native tissue repair and revascularization mechanisms. The end effector may optionally include an RF electrode to cause a controlled degree of necrosis, means for depositing a controlled amount of a bioactive agent at the treatment site, or both. The deflectable end region of the catheter provides precise control over the location of the end region, and thus, the end effector.
Referring to FIG. 1 , illustrative apparatus 20 constructed in accordance with the present invention is described. Apparatus 20 comprises catheter 21 having deflectable end region 22, end effector 23 and handle 24, cable 25 and controller 26. Apparatus 20 is coupled via cable 25 to controller 26. End effector 23, described in greater detail hereinbelow, pierces myocardial tissue, with or without coring, to attain a treatment goal.
In a preferred embodiment, wherein the end effector comprises a flexible wire having a sharpened tip, controller 26 includes a hydraulic or pneumatic piston, valve assembly and control logic for extending and retracting the end effector beyond the distal endface of end region 23 responsive to commands input at handle assembly 24 or a footpedal (not shown) Controller 26 optionally may further contain RF generator circuitry for energizing electrodes disposed on the end effector to cause a controlled degree of necrosis at the treatment site. Alternatively, or in addition, controller 26 may include a source of a bioactive agent, and means for delivering controlled amounts of the bioactive agent to the treatment site.
Referring now to FIG. 3 , end effector 23 and controller 26 of a first embodiment are described. In FIG. 4 , most of catheter 21 and handle 24 have been omitted for clarity. End effector 23 comprises tissue piercing cone 41 having optional first and second RF electrodes 42a and 42b, respectively. End effector preferably comprises a rigid material that retains a sharp tip, such as stainless steel Drive shaft 43, which extends through cable 25 of FIG. 1 , is coupled to end effector 23 via flexible coupling 44 at its distal end, and to piston 45 at its proximal end. Drive shaft 43 is disposed for reciprocation in end region 22 responsive to movement of piston 45. Drive shaft 43 may comprise a single or braided plastic or metal alloy wire, while flexible coupling 44 comprises a sturdy but flexible plastic or metal alloy.
Likewise, when valve 48 couples high pressure source 47 to pressure line 49b (but not 49a), and valve 51 couples low pressure source 50 to line 52a (but not 52b), piston 45 is driven in the proximal direction. Valves 48 and 51 are coupled by wiring (not shown) to control logic 54, which actuates the valves responsive to control commands received from handle assembly 26 or a footpedal (not shown). Cylinder 46 may employ any suitable medium for moving piston 45, and may be either pneumatic or hydraulic.
Referring now also to FIG. 6 3, when piston 45 is driven in the distal direction, end effector 23 extends beyond the distal endface of catheter 21 and pierces and extends into tissue T. End effector 23 thereby induces trauma to tissue T in the form of needle track N. If electrodes 42a and 42b and RF generator circuitry 55 are provided, control logic 55 may energize the electrodes to cause necrosis of tissue T in a region R surrounding the end effector. Control logic 54 then reverses the orientation of valves 48 and 51, thus causing end effector 23 to be retracted from tissue T and into end region 22.
Applicants expect that the trauma caused by needle track N will stimulate naturally occurring mechanisms to repair the wound at the treatment site. It is further expected that by generating a matrix of treatment sites, a network of small vessels may become established in the tissue as it heals. In addition, by providing a controlled degree of necrosis, a preselected degree of scar tissue may be induced, thus mimicking the conditions observed to induce revascularization at the margins of laser-formed TMR channels.
With respect to FIGS. 5 and 6 , an alternative embodiment of the end effector and controller of the present invention is described. Once again, catheter 21 (except for end region 22) and handle 24 have been omitted from FIG. 5 for clarity End effector 60 comprises non-coring tissue piercing cone 61 affixed to drive shaft 62. Drive shaft 62 includes lumen 63, and extends through cable 25 of FIG. 1 Drive shaft 62 is coupled to piston 64 at its proximal end, and is disposed for reciprocation in the guide tube (not shown) responsive to movement of piston 64. Drive shaft 62 preferably comprises a thin-walled but flexible plastic or metal alloy tube. End effector 60 may optionally include electrodes 65a and 65b for applying an RF voltage potential to the tissue to cause a controlled degree of necrosis, as described hereinabove with respect to the embodiment of FIGS. 3 and 4 .
Drive shaft 62 includes a plurality of outlet ports 75 located adjacent to cone 61 and a plurality of inlet ports 76 disposed in chamber 77. Chamber 77 contains bioactive agent 80 suspended in a biocompatible high viscosity liquid or paste, and is selectively pressurized by pressure source 78. Bioactive agent 80, may comprise a drug or an angiogenic growth factor, for example, vascular endothelial growth factor (VEGF), fibroblast growth factor, type I (FGF-I) or type II (FGF-II), a gene vector, cardio myocytes, or other suitable agent for stimulating tissue growth and/or revascularization.
With respect to FIG. 6 , when piston 64 is driven in the distal direction, end effector 60 extends beyond the distal endface of the catheter and pierces and extends into tissue T. End effector 60 thereby causes trauma to tissue T in the form of needle track N. Once end effector 60 reaches its maximum depth, control logic 74 actuates high pressure source 78, causing a controlled amount of bioactive agent 80 to be expelled through outlet ports 75 into the tissue.
If the bioactive agent exits the ports with sufficiently high velocity, it is expected that the bioactive agent will form pockets 81 in the tissue. Alternatively, if the bioactive agent exits outlet ports 75 at lower velocity, it is expected that the bioactive agent will form a layer that coats the interior surface of needle track N. Once the bioactive agent has been deposited, control logic 74 reverses the orientation of valves 68 and 71, thus causing end effector 60 to be retracted from tissue T and into the end region of the catheter. If provided, RF electrodes 65a and 65b may be activated to cauterize tissue in the vicinity of needle track N.
As described hereinabove, applicants expect that the trauma caused by needle track N will stimulate the release of naturally tissue regenerative mechanisms to repair the wound at the treatment site. Moreover, the introduction of bioactive agent 80 along needle track N is expected to further stimulate revascularization By generating a matrix of treatment sites within which a bioactive agent has been deposited, it may be possible to promote the development of a network of small vessels that will perfuse the tissue.
Referring now to FIGS. 7A–7C , operation of apparatus 20 in the context of treating a series of treatment sites to stimulate revascularization in left ventricular myocardium is described. In FIG. 7A , end region 22 of apparatus 20 is shown positioned in a patient's left ventricular cavity, using techniques which are per se known. Specifically, end region 22 of apparatus 20 is inserted via a femoral artery, and is maneuvered under fluoroscopic guidance in a retrograde manner up through the descending aorta, through aortic arch 201, and down through ascending aorta 202 and aortic valve 203 into left ventricle 204. As will of course be understood, insertion of apparatus 20 into the left ventricle is with end region 22 in its transit position.
Previously known imaging techniques, such as ultrasound, MRI scan, CT scan, or fluoroscopy, may be used to verify the location of the end region 22 within the heart. Alternatively, means may be provided in end region 22 for emitting an ultrasonic signal which is detectable using an ultrasound imaging system outside of the patient. For example, a piezo-electric transducer may be affixed to the tip of the catheter and tuned to a frequency of a color Doppler ultrasound imaging system so as to appear as a bright orange or yellow spot on the display of the ultrasound system. Yet another way to detect the location of end region 22 is by pinpointing the delay time of an EKG signal at the point of detection, using an electrode disposed in end region 22. By looking at the morphology as well as the temporal characteristics of the EKG signal, the vertical position of the catheter within the heart chamber may be determined.
Referring to FIG. 7B , once end region is located adjacent a desired portion of the endocardial surface, end region 22 is deflected to its working position, for example, by operating control wire 27. In this manner end effector 23 is disposed against a surface of the endocardium to be treated.
As shown in FIG. 7C , a series of vertically aligned spaced-apart needle tracks 207 may he formed in left ventricular wall 206 by repositioning end region 22 using control wire 27. End effector 23 is then advanced to form a further needle track 207 in the tissue.
The foregoing methods enable a matrix of channels to be formed illustratively in the left ventricular wall. It will of course be understood that the same steps may be performed in mirror image to produce a series of needle tracks in the septal region. It is believed that the needle tracks may have a beneficial effect if formed anywhere on the walls of the heart chamber, including the septum, apex and left ventricular wall; the above-described apparatus provides this capability
In addition, a stabilization assembly may be employed, for example, as described in copending, commonly assigned U.S. patent application Ser. No. 08/863,877, filed May 27, 1997, to counteract any reaction forces generated by operation of end effector 23.
In FIG. 8 , an alternative arrangement for driving the end effector of the present invention is described. In controller 130 of FIG. 8 , the piston and cylinder of controller 26 of FIG. 1 are replaced with a mechanical drive system. As in FIGS. 3 and 4 , most of the catheter and handle have been omitted for clarity. End effector 131 comprises non-coring sharpened tip 132 coupled to drive shaft 133. Drive shaft 133 is coupled at its proximal end to push rod 134. Push rod 134 is biased against eccentric cam 135 by spring 136. Cam 135 is mounted on motor 137, which rotates cam 135 through one revolution responsive to commands from control logic 138. Control logic 138, in turn, actuates motor 137 responsive to commands received, for example, by a button on handle 24 (see FIG. 1 ). Thus, controller 130 extends and retracts end effector 131 to create a needle track in the tissue.
As will of course be apparent to one of skill in designing catheter-based systems, controller 130 may optionally include either the RF generator circuitry and electrodes of the embodiment of FIG. 3 , the bioactive agent delivery system described with respect to the embodiment of FIG. 5 , or both. As will be further apparent, the specific drive arrangements described hereinabove are intended to be illustrative, and other mechanisms may be readily employed. For example, the specific configuration of the pressure sources, pressure lines and the valves in FIGS. 3 and 5 are intended to be merely illustrative. Equivalent mechanisms for extending and retracting the end effector may be readily employed within the scope of the present invention. Thus, for example, the end effector may be spring loaded so as to be biased in the extended position and reset after having been extended to form each needle track.
Referring now to FIGS. 9 , 10A and 10B, a further alternative embodiment of a drive system and end effector suitable for use in the present invention are described. In apparatus 140 of FIG. 9 , it is again to be understood that the handle and most of the catheter have been omitted for clarity In apparatus 140, a manual drive arrangement has been substituted for the controller of the previously described embodiments. In particular, end effector 142 comprises tip 143 having aperture 144 coupled to the distal end of drive shaft 145. Proximal end 146 of drive shaft 145 includes actuator ring 147, and proximal end 148 of catheter 141 includes rings 149. As will be apparent, drive shaft 144 may be driven in the distal direction to extend end effector 142 by squeezing actuator ring 147 towards rings 149.
With respect to FIG. 10A , drive shaft 145 includes lumen 150 and push wire 151 disposed within lumen 150. Push wire 151 terminates at its proximal end in a plurality of fine wires 152. Wires 152 may comprise, for example, nickel-titanium, and are constructed so that when they extend through aperture 144, the wires diverge (see FIG. 10B ). Push wire 151 extends through lumen 150 of drive shaft 145 and terminates in button 153. By gripping flange 154 provided on proximal end 146 of drive shaft 145, button 153 may be depressed toward flange 154, thereby extending wires 152 through aperture 144.
With respect to FIGS. 11A and 11B , an alternative embodiment of an end effector is described for depositing a bioactive agent in a pelletized form. In FIGS. 11 , it is to be understood that the handle assembly and most of the catheter have been omitted. End effector 160 comprises tube 161 including beveled non-coring tip 162 mounted in distal end 163 of catheter 164. Push rod 165 is disposed for reciprocation in lumen 166 of tube 161. As shown in FIG. 11B , catheter 164 includes lumen 167 in which tube 161 is disposed, and lumen 168 through which bioactive pellets 170, illustratively, spherical beads, are advanced to end effector 160. Lumen 168 includes passageway 169 through which a pellet passes to engage push rod 165 for delivery.
In accordance with one aspect of the present invention, pellets 170 comprise a bioactive agent, as described hereinabove, disposed in a biodegradable binder, such as polycaprolactone or polylactic acid. Pellets 170 are sized to advance through lumen 168 freely and without bunching, so that when posh rod is retracted in the proximal direction past the proximal edge of passageway 169, a single pellet 170 passes into lumen 166 of tube 161. While pellets 170 are illustrative spherical, it is to be understood that the bioactive agent may be readily formed into any of a number of other shapes, such as rods, cones, granules, etc., and that the above-described delivery system may be readily adapted to such other pelletized forms.
Referring now to FIGS. 12A to 12D , operation of the apparatus of FIGS. 11 is described. Apparatus including end effector 160 first is disposed within an internal organ, such as the left ventricle, as described hereinabove with respect to FIGS. 7A to 7C . End effector 160 then is oriented so as to be positioned at a desired angle, e.g. perpendicular, to tissue T to be treated. While end effector 160 is being maneuvered into position, posh rod 165 is extended so that distal endface 171 extends past the distal edge of passageway 169, thereby confining pellets 170 within lumen 168. End effector 160 is urged in the distal direction to form needle track N, and so that tip 162 penetrates tissue T until catheter 164 abuts against the endocardium (shown in FIG. 12A ).
Push rod 165 then is retracted in the proximal direction, so that distal endface 171 is positioned proximally of the proximal edge of passageway 169. This in turn permits a single pellet 170 to advance through passageway 169 into lumen 166, as shown in FIG. 12B . Because pellets 170 are preferably only slightly smaller than the diameter of lumen 166, when a single pellet 170 has advanced into lumen 166, it will block other pellets from passing through passageway 169 into lumen 166. Alternatively, pellets 170 may be sized so that a predetermined number of pellets pass into lumen 166 each time push rod 165 is retracted proximally.
Push rod 165 then is driven in the distal direction, urging pellet 170 to the end of needle track N, as illustrated in FIG. 12C If RF electrodes are provided on tip 162, such electrodes may be energized to necrose a predetermined thickness of tissue in the vicinity of tip 162. End effector 160 then is withdrawn, leaving pellet 170 within needle track N in tissue T. As described hereinabove, pellet 170 preferably comprises a biodegradable substance that elutes a suitable bioactive agent into the tissue surrounding the pellet over a preselected period of time. It is expected that by depositing a bioactive substance within tissue T, tissue revascularization and growth may be stimulated, as described hereinabove. End effector 160 then is moved to another location and the foregoing process repeated to seed a plurality of pellets 170.
While preferred illustrative embodiments of the invention are described above, it will he apparent to one skilled in the art that various changes and modifications may be made therein without departing from the invention, and the appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (60)
1. Apparatus for treating an interior region of a cardiac chamber, the apparatus comprising:
a catheter configured for insertion into a cardiac chamber, the catheter having a deflectable end region;
an end effector disposed within distal to the delectable end region, the end effector adapted to form a needle track at a treatment site in an interior region of the cardiac chamber, the end effector movable between a first position, wherein the end effector is retracted within the end region, and a second position, wherein the end effector is extended beyond a distal endface of the catheter; and
means for moving the end region between the first and second positions, wherein the end effector further comprises means for depositing a controlled amount of a bioactive agent at the treatment site and wherein the catheter has a plurality of lumens, one of which contains the bioactive agent and wherein the catheter has a conductor extending from a proximal end of the catheter to an electrode which is distal to the deflectable end region.
2. The apparatus of claim 1 wherein the end effector comprises a non-coring sharpened tip.
3. The apparatus of claim 1 wherein the end effector further comprises an electrode adapted to deliver RF energy to the treatment site.
4. The apparatus of claim 1 wherein the end effector further comprises a plurality of fine wires, the fine wires movable between a retracted position and an extended position, the plurality of fine wires forming a matrix of additional needle tracks at the treatment site when extended.
5. The apparatus of claim 1 wherein the end effector is coupled to a drive shaft, the apparatus further comprising a controller including a hydraulic mechanism coupled to the drive shaft to extend and retract the end effector.
6. The apparatus as defined in claim 1 wherein the end effector is coupled to a drive shaft, the apparatus further comprising a controller including a pneumatic mechanism coupled to the drive shaft to extend and retract the end effector.
7. The apparatus as defined in claim 1 wherein the end effector is coupled to a drive shaft, the apparatus further comprising a manually actuated mechanism coupled to the drive shaft to extend and retract the end effector.
8. Apparatus for treating an interior region of a cardiac chamber, the apparatus comprising:
a catheter having a deflectable end region;
an end effector adapted to form a needle track at a treatment site in an interior region of the cardiac chamber, the end effector movable between a first position, wherein the end effector is retracted within the end region, and a second position, wherein the end effector is extended beyond a distal endface of the catheter; and
means for depositing a bioactive agent in the needle track when the end effector is in the second position and wherein the catheter has a plurality of lumens, one of which contains the bioactive agent and wherein the catheter has a conductor extending from a proximal end of the catheter to an electrode which is distal to the deflectable end region.
9. The apparatus of claim 8 wherein the end effector comprises a non-curing sharpened tip.
10. The apparatus of claim 8 wherein the end effector further comprises an electrode adapted to deliver RF energy to the treatment site.
11. The apparatus of claim 10 wherein the bioactive agent is a fluid and the means for depositing comprises supplies the fluid to the end effector under pressure.
12. The apparatus of claim 8 wherein bioactive agent has a pellet form and the means for depositing the bioactive agent comprises a push rod.
13. A method of treating an interior region of a cardiac chamber the method comprising:
providing apparatus having a catheter adapted for insertion into a cardiac chamber, the catheter having a deflectable end region including an end effector adapted to form a needle track at a treatment site in an interior region of the cardiac chamber, wherein the catheter has a plurality of lumens, one of which contains a bioactive agent, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to the end effector;
inserting the apparatus within a cardiac chamber;
deflecting the end region to dispose the end effector at a selected orientation relative to an endocardial surface;
actuating the end effector to form a needle track in an interior region of the cardiac chamber at a treatment site; and
delivering a controlled amount of a the bioactive agent at the treatment site, wherein the needle track, after the delivering, is substantially closed onto the bioactive agent.
14. The method of claim 13 further comprising delivering RF energy to the treatment site to create a controlled depth of necrosis at the treatment site.
15. The method of claim 13 wherein delivering a controlled amount of a bioactive agent at the treatment site further comprises injecting the bioactive agent under pressure sufficient to form a pocket of bioactive agent in the tissue.
16. The method of claim 13 wherein delivering a controlled amount of a bioactive agent at the treatment site further comprises injecting a pellet comprising a bioactive agent.
17. The method as defined in claim 13 wherein the end effector further comprises a plurality of fine wires, the fine wires movable between a retracted position and an extended position, the method further comprising extending the plurality of fine wires to form a matrix of additional needle tracks at the treatment site.
18. The method as defined in claim 13 further comprising, following delivering a controlled amount of a bioactive agent at the treatment site:
translating the end region to relocate the end effector; and
repeating actuation of the end effector.
19. An apparatus, comprising:
a catheter configured for percutaneous insertion into a cardiac tissue, the catheter having a proximal region, a steerable distal region, and a lumen extending from the proximal region to the steerable distal region;
a needle disposed distal to the steerable distal region and movable between a first position, wherein the needle is retracted within the distal region, and a second position, wherein the needle is extended beyond the distal region; and
a controller coupled near the proximal region and having a source of a bioactive agent, wherein the controller mechanically measures a controlled amount of the bioactive agent, and wherein the bioactive agent is passed through the lumen, in fluid communication with the needle, for delivery into the cardiac tissue, wherein the needle further comprises a means for depositing the controlled amount of the bioactive agent into the cardiac tissue, and wherein the catheter has a plurality of lumens, one of which contains the bioactive agent and wherein the catheter has a conductor extending from a proximal end of the catheter to an electrode which is distal to the steerable distal region.
20. The apparatus of claim 19, wherein the bioactive agent has a pellet form.
21. The apparatus of claim 19, wherein the bioactive agent has a fluid form.
22. The apparatus of claim 19, wherein the controller releases a plurality of discrete units of the bioactive agent through the lumen of the needle.
23. The apparatus of claim 22, wherein the plurality of discrete units of the bioactive agent comprises a predetermined amount of the bioactive agent.
24. The apparatus of claim 19, wherein the needle further comprises an electrode adapted to delivery RF energy to the cardiac tissue.
25. The apparatus of claim 19, wherein the controller comprises a chamber adapted to contain the bioactive agent.
26. The apparatus of claim 19, further comprising a mechanical driver coupled near the proximal region, wherein the mechanical driver retracts and extends the needle a controlled depth into the cardiac tissue.
27. An apparatus, comprising:
a catheter configured for percutaneous insertion into a cardiac tissue, the catheter having a proximal region, a steerable distal region, and a lumen extending from the proximal region to the steerable distal region;
a needle disposed distal to the steerable distal region and movable between a first position, wherein the needle is retracted within the distal region, and a second position, wherein the needle is extended beyond the distal region; and
a controller coupled near the proximal region and having a source of a bioactive agent, wherein the controller passes a predetermined amount of the bioactive agent through the lumen, in fluid communication with the needle, for delivery into the cardiac tissue, wherein the needle further comprises a means for depositing the predetermined amount of the bioactive agent into the cardiac tissue, and wherein the catheter has a plurality of lumens, one of which contains the bioactive agent and wherein the catheter has a conductor extending from a proximal end of the catheter to an electrode which is distal to the steerable distal region.
28. The apparatus of claim 27, wherein the bioactive agent has a pellet form.
29. The apparatus of claim 27, wherein the bioactive agent has a fluid form.
30. The apparatus of claim 27, wherein the controller mechanically measures a controlled amount of the bioactive agent.
31. The apparatus of claim 27, wherein the needle further comprises an electrode adapted to delivery RF energy to the cardiac tissue.
32. The apparatus of claim 27, further comprising a mechanical driver coupled near the proximal region, wherein the mechanical driver retracts and extends the needle a controlled depth into the cardiac tissue.
33. A method for delivering a bioactive agent to a patient's cardiac tissue, the method comprising:
providing a catheter adapted for percutaneous insertion into the cardiac tissue, the catheter having a steerable end region and a hollow needle adapted to deliver discrete units of a bioactive agent having a predetermined dosage and a push rod to push the discrete units, wherein the catheter has a plurality of lumens, one of which contains the bioactive agent, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to an electrode which is distal to the steerable end region;
inserting the catheter within the cardiac tissue;
steering the steerable end region to dispose the hollow needle at a selected orientation relative to an interior surface of the cardiac tissue; and
delivering and mechanically measuring a controlled amount of the bioactive agent to the cardiac tissue.
34. The method of claim 33, further comprising delivering a plurality of discrete units of the bioactive agent to the cardiac tissue.
35. The method of claim 33 wherein delivering comprises injecting the bioactive agent under pressure sufficient to form a pocket of the bioactive agent in the cardiac tissue.
36. The method of claim 33 wherein delivering comprises injecting the bioactive agent in a pellet form.
37. The method of claim 33 wherein delivering comprises injecting the bioactive agent in a fluid form.
38. The method of claim 33, further comprising delivering RF energy to the cardiac tissue.
39. The method of claim 33, further comprising mechanically retracting and extending the needle a controlled depth into the cardiac tissue.
40. A method for delivering a bioactive agent to a patient's cardiac tissue, the method comprising:
providing a catheter adapted for percutaneous insertion into the cardiac tissue, the catheter having a steerable end region and a needle adapted to deliver discrete units of a bioactive agent having a predetermined dosage, wherein the catheter has a plurality of lumens, one of which contains the discrete units, and a push rod to push the discrete units, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to an electrode coupled to the needle near the steerable end region;
inserting the catheter within the cardiac tissue;
steering the steerable end region to dispose the needle at a selected orientation relative to an interior surface of the cardiac tissue; and
mechanically delivering the predetermined dosage of the bioactive agent through the needle into the cardiac tissue using the push rod.
41. The method of claim 40, further comprising delivering a plurality of discrete units of the bioactive agent to the treatment site.
42. The method of claim 41, further comprising mechanically measuring a controlled amount of the bioactive agent.
43. The method of claim 41 wherein delivering comprises injecting the bioactive agent under pressure sufficient to form a pocket of the bioactive agent in the cardiac tissue.
44. The method of claim 41 wherein delivering comprises injecting the bioactive agent in a pellet form.
45. The method of claim 41 wherein delivering comprises injecting the bioactive agent in a fluid form.
46. The method of claim 41, further comprising delivering RF energy to the cardiac tissue.
47. The method of claim 40, further comprising mechanically driving the needle to control a penetration depth of the needle into the cardiac tissue.
48. An apparatus for delivering a bioactive agent to a patient's cardiac tissue, the apparatus comprising:
means for providing a catheter adapted for percutaneous insertion into the cardiac tissue, the catheter having a steerable end region and a hollow needle adapted to deliver discrete units of a bioactive agent having a predetermined dosage, wherein the catheter has a plurality of lumens, one of which contains the discrete units, and a push rod to push the discrete units, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to an electrode which is distal to the steerable end region;
means for inserting the catheter within the cardiac tissue;
means for steering the steerable end region to dispose the hollow needle at a selected orientation relative to an interior surface of the cardiac tissue; and
means for delivering and mechanically measuring a controlled amount of the bioactive agent.
49. An apparatus for delivering a bioactive agent to a patient's cardiac tissue, the apparatus comprising:
means for providing a catheter adapted for percutaneous insertion into the cardiac tissue, the catheter having a steerable end region and a needle adapted to deliver discrete units of a bioactive agent having a predetermined dosage, wherein the catheter has a plurality of lumens, one of which contains the discrete units, and a push rod to push the discrete units, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to an electrode which is distal to the steerable end region;
means for inserting the catheter within the cardiac tissue;
means for steering the steerable end region to dispose the needle at a selected orientation relative to an interior surface of the cardiac tissue; and
means for mechanically delivering the predetermined dosage of the bioactive agent through the needle into the cardiac tissue.
50. An apparatus, comprising:
a catheter configured for percutaneous insertion into a cardiac tissue, the catheter having a proximal region, a steerable distal region which is deflectable, and a lumen extending from the proximal region to the steerable distal region;
a needle disposed distal to the steerable distal region and movable between a first position, wherein the needle is retracted within the distal region, and a second position, wherein the needle is extended beyond the distal region and wherein the needle is deflectable within the steerable distal region; and
a controller coupled near the proximal region and having a source of a bioactive agent in the form of discrete units, wherein the controller passes a predetermined amount of the bioactive agent through the lumen, in fluid communication with the needle, for delivery into the cardiac tissue, wherein the needle further comprises a means for depositing the predetermined amount of the bioactive agent into the cardiac tissue, and wherein the catheter has a plurality of lumens, one of which contains the bioactive agent and wherein the catheter has a conductor extending from a proximal end of the catheter to an electrode which is distal to the steerable distal region.
51. The apparatus of claim 50, wherein the bioactive agent has a pellet form.
52. A method for delivering a bioactive agent to a patient's cardiac tissue, the method comprising:
providing a catheter adapted for percutaneous insertion into the cardiac tissue, the catheter having a steerable end region and a hollow needle adapted to deliver granules of a bioactive agent having a predetermined dosage, wherein the catheter has a plurality of lumens, one of which contains the granules, and a push rod to push the granules, wherein the catheter has a plurality of lumens, one of which contains the bioactive agent, wherein the catheter has a conductor extending from the proximal end of the catheter to the distal end of the catheter and the conductor is coupled to an electrode which is distal to the steerable end region;
inserting the catheter within the cardiac tissue;
steering the steerable end region to dispose the hollow needle at a selected orientation relative to an interior surface of the cardiac tissue; and
mechanically delivering a controlled amount of the granules using the push rod.
53. The method of claim 52, wherein the catheter includes a plurality of granules.
54. The method of claim 53, wherein mechanically delivering comprises separating a single granule from the plurality of granules.
55. The method of claim 54 additionally comprising inserting a single granule within the cardiac tissue.
56. The method of claim 52 additionally comprising inserting at least one granule into the cardiac tissue and wherein the mechanically delivering comprises measuring the controlled amount.
57. The method of claim 52, wherein inserting comprises inserting the hollow needle into the cardiac tissue.
58. The method of claim 57, wherein a portion of the catheter allows only the hollow needle to insert into the cardiac tissue.
59. The method of claim 57, wherein a path into the cardiac tissue is created by inserting the hollow needle.
60. The method of claim 59, wherein the path substantially closes after the hollow needle is withdrawn from the cardiac tissue such that the granule is in complete contact with the cardiac tissue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/246,030 USRE42959E1 (en) | 1996-12-02 | 2002-09-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3219696P | 1996-12-02 | 1996-12-02 | |
US08/863,925 US5941893A (en) | 1996-12-02 | 1997-05-27 | Apparatus for transluminally performing surgery |
US08/863,877 US5910150A (en) | 1996-12-02 | 1997-05-27 | Apparatus for performing surgery |
US08/863,791 US5931848A (en) | 1996-12-02 | 1997-05-27 | Methods for transluminally performing surgery |
US09/271,094 US6120520A (en) | 1997-05-27 | 1999-03-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
US10/246,030 USRE42959E1 (en) | 1996-12-02 | 2002-09-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/271,094 Reissue US6120520A (en) | 1996-12-02 | 1999-03-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE42959E1 true USRE42959E1 (en) | 2011-11-22 |
Family
ID=23034170
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/271,094 Ceased US6120520A (en) | 1996-12-02 | 1999-03-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
US10/246,030 Expired - Lifetime USRE42959E1 (en) | 1996-12-02 | 2002-09-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/271,094 Ceased US6120520A (en) | 1996-12-02 | 1999-03-17 | Apparatus and methods for stimulating revascularization and/or tissue growth |
Country Status (3)
Country | Link |
---|---|
US (2) | US6120520A (en) |
AU (1) | AU3893300A (en) |
WO (1) | WO2000054660A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100234873A1 (en) * | 2007-11-27 | 2010-09-16 | Yoshitaka Nagano | Drive device, and medical apparatus and training apparatus including the same |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9413896B2 (en) | 2012-09-14 | 2016-08-09 | The Spectranetics Corporation | Tissue slitting methods and systems |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
US9603618B2 (en) | 2013-03-15 | 2017-03-28 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US9925366B2 (en) | 2013-03-15 | 2018-03-27 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US10136913B2 (en) | 2013-03-15 | 2018-11-27 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
US11554251B2 (en) * | 2019-04-30 | 2023-01-17 | Boston Scientific Scimed, Inc. | Endoscopic patch applicator |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6565562B1 (en) * | 1997-06-27 | 2003-05-20 | Baylis Medical Company Inc. | Method for the radio frequency perforation and the enlargement of a body tissue |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
WO2000015147A1 (en) | 1998-09-10 | 2000-03-23 | Percardia, Inc. | Transmycardial shunt and its attachment mechanism, for left ventricular revascularization |
US6409697B2 (en) | 1999-05-04 | 2002-06-25 | Heartstent Corporation | Transmyocardial implant with forward flow bias |
US6719778B1 (en) * | 2000-03-24 | 2004-04-13 | Endovascular Technologies, Inc. | Methods for treatment of aneurysms |
JP3782297B2 (en) * | 2000-03-28 | 2006-06-07 | 株式会社東芝 | Solid-state imaging device and manufacturing method thereof |
AU2001273421A1 (en) | 2000-07-13 | 2002-01-30 | Bioheart, Inc. | Deployment system for myocardial cellular material |
US6669691B1 (en) * | 2000-07-18 | 2003-12-30 | Scimed Life Systems, Inc. | Epicardial myocardial revascularization and denervation methods and apparatus |
US20020029037A1 (en) * | 2000-09-06 | 2002-03-07 | Kim Young D. | Method and apparatus for percutaneous trans-endocardial reperfusion |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6730102B1 (en) * | 2000-11-06 | 2004-05-04 | Abbott Laboratories | Systems, devices and methods for deploying needles |
US6692466B1 (en) | 2000-12-21 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Drug delivery catheter with retractable needle |
GB0100247D0 (en) * | 2001-01-05 | 2001-02-14 | Univ Dundee | Improved hypodermic needle and fluid injection device |
US6976990B2 (en) | 2001-01-25 | 2005-12-20 | Percardia, Inc. | Intravascular ventriculocoronary bypass via a septal passageway |
US6625486B2 (en) | 2001-04-11 | 2003-09-23 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for intracellular delivery of an agent |
US6702744B2 (en) * | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
DK1423066T3 (en) | 2001-09-07 | 2008-11-17 | Mardil Inc | Method and apparatus for external cardiac stabilization |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
US20070270793A1 (en) * | 2001-12-08 | 2007-11-22 | Lattouf Omar M | Methods for endocardial ablation |
US20080249504A1 (en) | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
US6955657B1 (en) * | 2001-12-31 | 2005-10-18 | Advanced Cardiovascular Systems, Inc. | Intra-ventricular substance delivery catheter system |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6949118B2 (en) | 2002-01-16 | 2005-09-27 | Percardia, Inc. | Encased implant and methods |
US7008397B2 (en) | 2002-02-13 | 2006-03-07 | Percardia, Inc. | Cardiac implant and methods |
US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
US6811777B2 (en) | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US7108685B2 (en) * | 2002-04-15 | 2006-09-19 | Boston Scientific Scimed, Inc. | Patch stabilization of rods for treatment of cardiac muscle |
US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
US7326219B2 (en) | 2002-09-09 | 2008-02-05 | Wilk Patent Development | Device for placing transmyocardial implant |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US9149602B2 (en) | 2005-04-22 | 2015-10-06 | Advanced Cardiovascular Systems, Inc. | Dual needle delivery system |
US8187324B2 (en) * | 2002-11-15 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Telescoping apparatus for delivering and adjusting a medical device in a vessel |
US7981152B1 (en) | 2004-12-10 | 2011-07-19 | Advanced Cardiovascular Systems, Inc. | Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites |
US6928669B2 (en) * | 2003-01-10 | 2005-08-16 | Tyler Pipe Company | Closet carrier system and method of assembly |
US20040199179A1 (en) * | 2003-04-02 | 2004-10-07 | Elliott Christopher J. | Steerable ablation probe |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8383158B2 (en) | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US8308708B2 (en) | 2003-07-15 | 2012-11-13 | Abbott Cardiovascular Systems Inc. | Deployment system for myocardial cellular material |
US7998112B2 (en) | 2003-09-30 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly and method of making same |
US7273469B1 (en) * | 2003-12-31 | 2007-09-25 | Advanced Cardiovascular Systems, Inc. | Modified needle catheter for directional orientation delivery |
US7862811B2 (en) * | 2004-02-27 | 2011-01-04 | Regents Of The University Of Colorado | Protease inhibition for prevention or treatment of heart failure |
WO2005086874A2 (en) * | 2004-03-11 | 2005-09-22 | Medrad, Inc. | Energy assisted medical devices, systems and methods |
US20050226991A1 (en) * | 2004-04-07 | 2005-10-13 | Hossainy Syed F | Methods for modifying balloon of a catheter assembly |
US20060004431A1 (en) | 2004-07-01 | 2006-01-05 | Fuller Thomas A | Prophylactic bactericidal implant |
US7632262B2 (en) * | 2004-07-19 | 2009-12-15 | Nexeon Medical Systems, Inc. | Systems and methods for atraumatic implantation of bio-active agents |
US7462268B2 (en) * | 2004-08-20 | 2008-12-09 | Allan Mishra | Particle/cell separation device and compositions |
US7819856B2 (en) * | 2004-10-05 | 2010-10-26 | Nexeon Medical Systems, Inc. | Methods and apparatus for treating infarcted regions of tissue following acute myocardial infarction |
US7854944B2 (en) | 2004-12-17 | 2010-12-21 | Advanced Cardiovascular Systems, Inc. | Tissue regeneration |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8182433B2 (en) | 2005-03-04 | 2012-05-22 | Endosense Sa | Medical apparatus system having optical fiber load sensing capability |
US8075498B2 (en) | 2005-03-04 | 2011-12-13 | Endosense Sa | Medical apparatus system having optical fiber load sensing capability |
US20060263338A1 (en) * | 2005-03-04 | 2006-11-23 | Jacoby Douglas B | Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
CA2541108A1 (en) * | 2005-03-31 | 2006-09-30 | Sherwood Services Ag | Electrosurgical cannulas, systems and method |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US8303972B2 (en) | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
JP2009502302A (en) * | 2005-07-25 | 2009-01-29 | グロス,ヨシ | Electrical stimulation of blood vessels |
EP3028645B1 (en) | 2005-08-01 | 2019-09-18 | St. Jude Medical International Holding S.à r.l. | Medical apparatus system having optical fiber load sensing capability |
US20080249525A1 (en) * | 2005-11-08 | 2008-10-09 | U & I Corporation | Radio Frequency Ablation Electrode for Selected Tissue Removal |
US8567265B2 (en) | 2006-06-09 | 2013-10-29 | Endosense, SA | Triaxial fiber optic force sensing catheter |
US8048063B2 (en) | 2006-06-09 | 2011-11-01 | Endosense Sa | Catheter having tri-axial force sensor |
US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
US8118803B1 (en) | 2006-12-19 | 2012-02-21 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly |
WO2008082586A2 (en) | 2006-12-28 | 2008-07-10 | Fuller Thomas A | Ex vivo antimicrobial devices and methods |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8157789B2 (en) | 2007-05-24 | 2012-04-17 | Endosense Sa | Touch sensing catheter |
US8622935B1 (en) | 2007-05-25 | 2014-01-07 | Endosense Sa | Elongated surgical manipulator with body position and distal force sensing |
ES2325715B1 (en) | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | POPULATION OF ADULT MOTHER CELLS DERIVED FROM CARDIAC ADIPOSE TISSUE AND ITS USE IN CARDIAC REGENERATION. |
US8538535B2 (en) | 2010-08-05 | 2013-09-17 | Rainbow Medical Ltd. | Enhancing perfusion by contraction |
US8626299B2 (en) | 2008-01-31 | 2014-01-07 | Enopace Biomedical Ltd. | Thoracic aorta and vagus nerve stimulation |
US8626290B2 (en) | 2008-01-31 | 2014-01-07 | Enopace Biomedical Ltd. | Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta |
US9005106B2 (en) * | 2008-01-31 | 2015-04-14 | Enopace Biomedical Ltd | Intra-aortic electrical counterpulsation |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US8298227B2 (en) * | 2008-05-14 | 2012-10-30 | Endosense Sa | Temperature compensated strain sensing catheter |
US20100112081A1 (en) | 2008-10-07 | 2010-05-06 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
EP2477617B1 (en) | 2009-09-18 | 2018-01-31 | Bioinspire Technologies Inc. | Free-standing biodegradable patch |
US9795765B2 (en) | 2010-04-09 | 2017-10-24 | St. Jude Medical International Holding S.À R.L. | Variable stiffness steering mechanism for catheters |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US8649863B2 (en) | 2010-12-20 | 2014-02-11 | Rainbow Medical Ltd. | Pacemaker with no production |
EP2696777B1 (en) | 2011-04-14 | 2020-08-05 | St. Jude Medical International Holding S.à r.l. | Catheter assembly with optical force sensor |
US9526637B2 (en) | 2011-09-09 | 2016-12-27 | Enopace Biomedical Ltd. | Wireless endovascular stent-based electrodes |
US8855783B2 (en) | 2011-09-09 | 2014-10-07 | Enopace Biomedical Ltd. | Detector-based arterial stimulation |
CN104125840B (en) * | 2011-10-04 | 2016-11-09 | 因库博实验室有限责任公司 | Solid chemicals delivery apparatus, preparation and using method |
US9386991B2 (en) | 2012-02-02 | 2016-07-12 | Rainbow Medical Ltd. | Pressure-enhanced blood flow treatment |
US20150151077A1 (en) * | 2012-06-13 | 2015-06-04 | Douglas C. Harrington | Devices And Methods For Renal Denervation |
US9393364B2 (en) | 2012-07-17 | 2016-07-19 | Cook Medical Technologies Llc | Multi-lumen biologic-delivering device |
EP2968752B1 (en) | 2013-03-15 | 2023-09-06 | Muffin Incorporated | Cell injection needle |
US9855404B2 (en) | 2013-05-03 | 2018-01-02 | St. Jude Medical International Holding S.À R.L. | Dual bend radii steering catheter |
US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
CN108836586B (en) | 2013-11-06 | 2021-04-06 | 伊诺佩斯生医有限公司 | Wireless intravascular stent-based electrode |
KR20170095932A (en) | 2014-12-23 | 2017-08-23 | 메조블라스트 인터내셔널 에스에이알엘 | Method for treating heart failure |
EP3632378B1 (en) | 2015-05-01 | 2024-05-29 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
US11445937B2 (en) | 2016-01-07 | 2022-09-20 | St. Jude Medical International Holding S.À R.L. | Medical device with multi-core fiber for optical sensing |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
JP6908329B2 (en) * | 2018-11-21 | 2021-07-21 | タウ ピーエヌユー メディカル カンパニー, リミテッド | RF electrode resection catheter for hypertrophic cardiomyopathy surgery |
US20220160776A1 (en) | 2019-01-28 | 2022-05-26 | Mesoblast International Sárl | Method for treating or preventing gastrointestinal bleeding |
US11490944B2 (en) * | 2019-08-13 | 2022-11-08 | Avent, Inc. | System and method to map active RF channels to respective pump heads for cooled radiofrequency ablation |
CA3202441A1 (en) * | 2020-12-16 | 2022-06-23 | Eric William Brader | Transmyocardial jet perfusion device |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Citations (216)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1162901A (en) | 1915-10-08 | 1915-12-07 | Edward B Cantey | Instrument for cutting cores from solid substances. |
US2710000A (en) | 1952-02-19 | 1955-06-07 | Cromer Jeremiah Keith | Cutting instrument |
US2749909A (en) | 1956-06-12 | Biopsy knife | ||
US3120845A (en) | 1961-02-20 | 1964-02-11 | David B Horner | Self-powered surgical drill |
US3470876A (en) | 1966-09-28 | 1969-10-07 | John Barchilon | Dirigible catheter |
US3477423A (en) | 1967-01-09 | 1969-11-11 | Baxter Laboratories Inc | Biopsy instrument |
US3557794A (en) | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US3614953A (en) | 1968-01-30 | 1971-10-26 | Nat Res Dev | Drills for clearing obstructions in arteries |
US3692020A (en) | 1971-04-29 | 1972-09-19 | Robert J Schied | Rotary punch for excising uniform diopsy specimens |
US3780246A (en) | 1972-08-22 | 1973-12-18 | Black & Decker Mfg Co | Hand-operated tool with switch actuator having three-position lock-off assembly |
US4207874A (en) | 1978-03-27 | 1980-06-17 | Choy Daniel S J | Laser tunnelling device |
US4362161A (en) | 1980-10-27 | 1982-12-07 | Codman & Shurtleff, Inc. | Cranial drill |
US4381037A (en) | 1979-10-29 | 1983-04-26 | Black & Decker Inc. | Portable electric tool |
US4461305A (en) | 1981-09-04 | 1984-07-24 | Cibley Leonard J | Automated biopsy device |
US4468224A (en) | 1982-01-28 | 1984-08-28 | Advanced Cardiovascular Systems, Inc. | System and method for catheter placement in blood vessels of a human patient |
US4479896A (en) | 1981-12-11 | 1984-10-30 | Antoniades Harry N | Method for extraction localization and direct recovery of platelet derived growth factor |
US4576162A (en) | 1983-03-30 | 1986-03-18 | Mccorkle Charles E | Apparatus and method for separation of scar tissue in venous pathway |
US4578057A (en) | 1984-08-31 | 1986-03-25 | Cordis Corporation | Ventricular right angle connector and system |
US4582056A (en) | 1983-03-30 | 1986-04-15 | Mccorkle Jr Charles E | Endocardial lead extraction apparatus and method |
WO1986003122A1 (en) | 1984-11-29 | 1986-06-05 | Curatech, Inc. | Wound healing agents |
US4600014A (en) | 1984-02-10 | 1986-07-15 | Dan Beraha | Transrectal prostate biopsy device and method |
US4640296A (en) | 1983-11-12 | 1987-02-03 | Schnepp Pesch Wolfram | Biopsy cannula |
US4646738A (en) | 1985-12-05 | 1987-03-03 | Concept, Inc. | Rotary surgical tool |
US4702261A (en) | 1985-07-03 | 1987-10-27 | Sherwood Medical Company | Biopsy device and method |
US4729763A (en) | 1986-06-06 | 1988-03-08 | Henrie Rodney A | Catheter for removing occlusive material |
US4788975A (en) | 1987-11-05 | 1988-12-06 | Medilase, Inc. | Control system and method for improved laser angioplasty |
US4790812A (en) | 1985-11-15 | 1988-12-13 | Hawkins Jr Irvin F | Apparatus and method for removing a target object from a body passsageway |
US4792327A (en) | 1986-09-15 | 1988-12-20 | Barry Swartz | Lipectomy cannula |
US4813930A (en) | 1987-10-13 | 1989-03-21 | Dimed, Inc. | Angioplasty guiding catheters and methods for performing angioplasty |
US4850354A (en) | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4856529A (en) | 1985-05-24 | 1989-08-15 | Cardiometrics, Inc. | Ultrasonic pulmonary artery catheter and method |
US4895166A (en) | 1987-11-23 | 1990-01-23 | Interventional Technologies, Inc. | Rotatable cutter for the lumen of a blood vesel |
US4898577A (en) | 1988-09-28 | 1990-02-06 | Advanced Cardiovascular Systems, Inc. | Guiding cathether with controllable distal tip |
US4917102A (en) | 1988-09-14 | 1990-04-17 | Advanced Cardiovascular Systems, Inc. | Guidewire assembly with steerable adjustable tip |
US4923462A (en) | 1987-03-17 | 1990-05-08 | Cordis Corporation | Catheter system having a small diameter rotatable drive member |
USRE33258E (en) | 1984-07-23 | 1990-07-10 | Surgical Dynamics Inc. | Irrigating, cutting and aspirating system for percutaneous surgery |
US4957742A (en) | 1984-11-29 | 1990-09-18 | Regents Of The University Of Minnesota | Method for promoting hair growth |
US4964854A (en) | 1989-01-23 | 1990-10-23 | Luther Medical Products, Inc. | Intravascular catheter assembly incorporating needle tip shielding cap |
US4976710A (en) | 1987-01-28 | 1990-12-11 | Mackin Robert A | Working well balloon method |
US4985028A (en) | 1989-08-30 | 1991-01-15 | Angeion Corporation | Catheter |
US5030201A (en) | 1989-11-24 | 1991-07-09 | Aubrey Palestrant | Expandable atherectomy catheter device |
US5087265A (en) | 1989-02-17 | 1992-02-11 | American Biomed, Inc. | Distal atherectomy catheter |
US5093877A (en) | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5104393A (en) | 1989-08-30 | 1992-04-14 | Angelase, Inc. | Catheter |
US5106386A (en) | 1989-08-30 | 1992-04-21 | Angelase, Inc. | Catheter |
US5123904A (en) | 1988-04-28 | 1992-06-23 | Olympus Optical Co., Ltd. | Surgical resecting instrument |
WO1992010142A1 (en) | 1990-12-10 | 1992-06-25 | Howmedica Inc. | A device and method for interstitial laser energy delivery |
US5125926A (en) | 1990-09-24 | 1992-06-30 | Laser Engineering, Inc. | Heart-synchronized pulsed laser system |
US5125924A (en) | 1990-09-24 | 1992-06-30 | Laser Engineering, Inc. | Heart-synchronized vacuum-assisted pulsed laser system and method |
US5133713A (en) | 1990-03-27 | 1992-07-28 | Huang Jong Khing | Apparatus of a spinning type of resectoscope for prostatectomy |
US5135531A (en) | 1984-05-14 | 1992-08-04 | Surgical Systems & Instruments, Inc. | Guided atherectomy system |
US5152744A (en) | 1990-02-07 | 1992-10-06 | Smith & Nephew Dyonics | Surgical instrument |
US5195988A (en) | 1988-05-26 | 1993-03-23 | Haaga John R | Medical needle with removable sheath |
US5197968A (en) | 1991-08-14 | 1993-03-30 | Mectra Labs, Inc. | Disposable tissue retrieval assembly |
US5224951A (en) | 1991-02-19 | 1993-07-06 | Dexide, Inc. | Surgical trocar and spike assembly |
US5242460A (en) | 1990-10-25 | 1993-09-07 | Devices For Vascular Intervention, Inc. | Atherectomy catheter having axially-disposed cutting edge |
US5263959A (en) | 1991-10-21 | 1993-11-23 | Cathco, Inc. | Dottering auger catheter system and method |
US5269785A (en) | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
US5273051A (en) | 1993-03-16 | 1993-12-28 | Wilk Peter J | Method and associated device for obtaining a biopsy of tissues of an internal organ |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5285795A (en) | 1991-09-12 | 1994-02-15 | Surgical Dynamics, Inc. | Percutaneous discectomy system having a bendable discectomy probe and a steerable cannula |
US5287861A (en) | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5292309A (en) | 1993-01-22 | 1994-03-08 | Schneider (Usa) Inc. | Surgical depth measuring instrument and method |
US5313949A (en) | 1986-02-28 | 1994-05-24 | Cardiovascular Imaging Systems Incorporated | Method and apparatus for intravascular two-dimensional ultrasonography |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5323781A (en) | 1992-01-31 | 1994-06-28 | Duke University | Methods for the diagnosis and ablation treatment of ventricular tachycardia |
US5330466A (en) | 1992-12-01 | 1994-07-19 | Cardiac Pathways Corporation | Control mechanism and system and method for steering distal extremity of a flexible elongate member |
US5336237A (en) | 1993-08-25 | 1994-08-09 | Devices For Vascular Intervention, Inc. | Removal of tissue from within a body cavity |
US5339799A (en) | 1991-04-23 | 1994-08-23 | Olympus Optical Co., Ltd. | Medical system for reproducing a state of contact of the treatment section in the operation unit |
US5342300A (en) | 1992-03-13 | 1994-08-30 | Stefanadis Christodoulos I | Steerable stent catheter |
US5342393A (en) | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
US5354310A (en) | 1993-03-22 | 1994-10-11 | Cordis Corporation | Expandable temporary graft |
US5358485A (en) | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5358472A (en) | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Guidewire atherectomy catheter and method of using the same |
US5366490A (en) | 1992-08-12 | 1994-11-22 | Vidamed, Inc. | Medical probe device and method |
US5366468A (en) | 1993-11-09 | 1994-11-22 | Linvatec Corporation | Double bladed surgical router having aspiration ports within flutes |
US5380316A (en) | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5379772A (en) | 1993-09-14 | 1995-01-10 | Intelliwire, Inc. | Flexible elongate device having forward looking ultrasonic imaging |
US5383884A (en) | 1992-12-04 | 1995-01-24 | American Biomed, Inc. | Spinal disc surgical instrument |
US5389073A (en) | 1992-12-01 | 1995-02-14 | Cardiac Pathways Corporation | Steerable catheter with adjustable bend location |
US5389096A (en) | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5392917A (en) | 1993-08-03 | 1995-02-28 | Ethicon, Inc. | Easy open 1-2-3 instrumentation package |
US5396897A (en) | 1992-01-16 | 1995-03-14 | The General Hospital Corporation | Method for locating tumors prior to needle biopsy |
US5403334A (en) | 1989-09-12 | 1995-04-04 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5409000A (en) | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
US5419777A (en) | 1994-03-10 | 1995-05-30 | Bavaria Medizin Technologie Gmbh | Catheter for injecting a fluid or medicine |
US5425376A (en) | 1993-09-08 | 1995-06-20 | Sofamor Danek Properties, Inc. | Method and apparatus for obtaining a biopsy sample |
US5429144A (en) | 1992-10-30 | 1995-07-04 | Wilk; Peter J. | Coronary artery by-pass method |
US5439474A (en) | 1993-10-08 | 1995-08-08 | Li Medical Technologies, Inc. | Morcellator system |
US5443443A (en) | 1984-05-14 | 1995-08-22 | Surgical Systems & Instruments, Inc. | Atherectomy system |
US5456689A (en) | 1993-10-13 | 1995-10-10 | Arnold J. Kresch | Method and device for tissue resection |
US5464395A (en) | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5488958A (en) | 1992-11-09 | 1996-02-06 | Vance Products Incorporated | Surgical cutting instrument for coring tissue affixed thereto |
US5492119A (en) | 1993-12-22 | 1996-02-20 | Heart Rhythm Technologies, Inc. | Catheter tip stabilizing apparatus |
US5497784A (en) | 1991-11-18 | 1996-03-12 | Intelliwire, Inc. | Flexible elongate device having steerable distal extremity |
US5505725A (en) | 1990-10-30 | 1996-04-09 | Cardiogenesis Corporation | Shapeable optical fiber apparatus |
US5507802A (en) | 1993-06-02 | 1996-04-16 | Cardiac Pathways Corporation | Method of mapping and/or ablation using a catheter having a tip with fixation means |
US5520634A (en) | 1993-04-23 | 1996-05-28 | Ethicon, Inc. | Mechanical morcellator |
US5531780A (en) | 1992-09-03 | 1996-07-02 | Pacesetter, Inc. | Implantable stimulation lead having an advanceable therapeutic drug delivery system |
WO1996025097A1 (en) | 1995-02-17 | 1996-08-22 | Ep Technologies, Inc. | Systems and methods for examining heart tissue |
US5551427A (en) | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
WO1996026675A1 (en) | 1995-02-28 | 1996-09-06 | Boston Scientific Corporation | Deflectable catheter for ablating cardiac tissue |
US5562694A (en) | 1994-10-11 | 1996-10-08 | Lasersurge, Inc. | Morcellator |
US5569284A (en) | 1994-09-23 | 1996-10-29 | United States Surgical Corporation | Morcellator |
US5569178A (en) | 1995-10-20 | 1996-10-29 | Henley; Julian L. | Power assisted suction lipectomy device |
US5569254A (en) | 1995-04-12 | 1996-10-29 | Midas Rex Pneumatic Tools, Inc. | Surgical resection tool having an irrigation, lighting, suction and vision attachment |
WO1996035469A1 (en) | 1995-05-10 | 1996-11-14 | Cardiogenesis Corporation | System for treating or diagnosing heart tissue |
US5575293A (en) | 1995-02-06 | 1996-11-19 | Promex, Inc. | Apparatus for collecting and staging tissue |
US5575787A (en) | 1993-09-20 | 1996-11-19 | Abela Laser Systems, Inc. | Cardiac ablation catheters and method |
US5575772A (en) | 1993-07-01 | 1996-11-19 | Boston Scientific Corporation | Albation catheters |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5578067A (en) | 1994-04-14 | 1996-11-26 | Pacesetter Ab | Medical electrode system having a sleeve body and control element therefor for selectively positioning an exposed conductor area |
US5584842A (en) | 1992-12-02 | 1996-12-17 | Intramed Laboratories, Inc. | Valvulotome and method of using |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US5591159A (en) | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5593405A (en) | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5601586A (en) | 1992-09-30 | 1997-02-11 | Linvatec Corporation | Variable angle rotating shaver |
US5601588A (en) | 1994-09-29 | 1997-02-11 | Olympus Optical Co., Ltd. | Endoscopic puncture needle |
US5601573A (en) | 1994-03-02 | 1997-02-11 | Ethicon Endo-Surgery, Inc. | Sterile occlusion fasteners and instruments and method for their placement |
US5607421A (en) | 1991-05-01 | 1997-03-04 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5606974A (en) | 1995-05-02 | 1997-03-04 | Heart Rhythm Technologies, Inc. | Catheter having ultrasonic device |
US5609591A (en) | 1993-10-05 | 1997-03-11 | S.L.T. Japan Co., Ltd. | Laser balloon catheter apparatus |
US5609621A (en) | 1995-08-04 | 1997-03-11 | Medtronic, Inc. | Right ventricular outflow tract defibrillation lead |
US5611803A (en) | 1994-12-22 | 1997-03-18 | Urohealth Systems, Inc. | Tissue segmentation device |
US5613972A (en) | 1992-07-15 | 1997-03-25 | The University Of Miami | Surgical cutting heads with curled cutting wings |
WO1997010753A1 (en) | 1995-09-20 | 1997-03-27 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
WO1997013471A1 (en) | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
US5640955A (en) | 1995-02-14 | 1997-06-24 | Daig Corporation | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
US5643253A (en) | 1995-06-06 | 1997-07-01 | Rare Earth Medical, Inc. | Phototherapy apparatus with integral stopper device |
US5651781A (en) | 1995-04-20 | 1997-07-29 | Grace-Wells Technology Partners No. 1, L.P. | Surgical cutting instrument |
US5658263A (en) | 1995-05-18 | 1997-08-19 | Cordis Corporation | Multisegmented guiding catheter for use in medical catheter systems |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5662124A (en) | 1996-06-19 | 1997-09-02 | Wilk Patent Development Corp. | Coronary artery by-pass method |
US5665062A (en) | 1995-01-23 | 1997-09-09 | Houser; Russell A. | Atherectomy catheter and RF cutting method |
US5669920A (en) | 1993-07-09 | 1997-09-23 | Devices For Vascular Intervention, Inc. | Atherectomy catheter |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5683362A (en) | 1994-05-13 | 1997-11-04 | Rowland; Christopher A. | Apparatus for performing diagnostic and therapeutic modalities in the biliary tree |
US5688234A (en) | 1996-01-26 | 1997-11-18 | Cardiometrics Inc. | Apparatus and method for the treatment of thrombotic occlusions in vessels |
EP0807412A1 (en) | 1996-05-13 | 1997-11-19 | United States Surgical Corporation | Coring device and method |
US5702412A (en) | 1995-10-03 | 1997-12-30 | Cedars-Sinai Medical Center | Method and devices for performing vascular anastomosis |
US5709697A (en) | 1995-11-22 | 1998-01-20 | United States Surgical Corporation | Apparatus and method for removing tissue |
WO1998005307A1 (en) | 1996-08-08 | 1998-02-12 | Localmed, Inc. | Transmural drug delivery method and apparatus |
US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
US5724975A (en) | 1996-12-12 | 1998-03-10 | Plc Medical Systems, Inc. | Ultrasonic detection system for transmyocardial revascularization |
US5725521A (en) | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
US5743870A (en) | 1994-05-09 | 1998-04-28 | Somnus Medical Technologies, Inc. | Ablation apparatus and system for removal of soft palate tissue |
WO1998017186A1 (en) | 1996-10-21 | 1998-04-30 | Plc Medical Systems, Inc. | Percutaneous transmyocardial revascularization marking system |
US5755714A (en) | 1996-09-17 | 1998-05-26 | Eclipse Surgical Technologies, Inc. | Shaped catheter for transmyocardial revascularization |
US5766163A (en) | 1996-07-03 | 1998-06-16 | Eclipse Surgical Technologies, Inc. | Controllable trocar for transmyocardial revascularization (TMR) via endocardium method and apparatus |
US5776092A (en) | 1994-03-23 | 1998-07-07 | Erbe Elektromedizin Gmbh | Multifunctional surgical instrument |
US5782823A (en) | 1996-04-05 | 1998-07-21 | Eclipse Surgical Technologies, Inc. | Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium |
EP0853921A2 (en) | 1996-12-27 | 1998-07-22 | Eclipse Surgical Technologies, Inc. | Laser assisted drug delivery |
US5797870A (en) | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
WO1998038916A1 (en) | 1997-03-07 | 1998-09-11 | Cardiogenesis Corporation | Apparatus and method of myocardial revascularization using ultrasonic pulse-echo distance ranging |
WO1998039045A1 (en) | 1997-03-07 | 1998-09-11 | Cardiogenesis Corporation | Catheter with three sections of different flexibilities |
US5807384A (en) | 1996-12-20 | 1998-09-15 | Eclipse Surgical Technologies, Inc. | Transmyocardial revascularization (TMR) enhanced treatment for coronary artery disease |
US5807401A (en) | 1994-11-07 | 1998-09-15 | Grieshaber & Co. Ag Schaffhausen | Ophthalmic surgical apparatus for pulverizing and removing the lens nucleus from the eye of a living being |
US5814028A (en) | 1993-11-03 | 1998-09-29 | Daig Corporation | Curved guiding introducers for cardiac access |
EP0868923A2 (en) | 1997-04-04 | 1998-10-07 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US5830210A (en) | 1996-10-21 | 1998-11-03 | Plc Medical Systems, Inc. | Catheter navigation apparatus |
US5834418A (en) | 1996-03-20 | 1998-11-10 | Theratechnologies, Inc. | Process for the preparation of platelet growth factors extract |
EP0876796A2 (en) | 1997-05-07 | 1998-11-11 | Eclipse Surgical Technologies, Inc. | Device for use in the treatment of cardiovascular or other tissue |
US5840059A (en) | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
US5846225A (en) | 1997-02-19 | 1998-12-08 | Cornell Research Foundation, Inc. | Gene transfer therapy delivery device and method |
US5851171A (en) | 1997-11-04 | 1998-12-22 | Advanced Cardiovascular Systems, Inc. | Catheter assembly for centering a radiation source within a body lumen |
US5857995A (en) | 1996-08-15 | 1999-01-12 | Surgical Dynamics, Inc. | Multiple bladed surgical cutting device removably connected to a rotary drive element |
EP0895752A1 (en) | 1997-08-08 | 1999-02-10 | Eclipse Surgical Technologies, Inc. | Apparatus for sampling heart tissue and/or myocardial revascularization by mechanical cutting |
US5871495A (en) | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5873366A (en) | 1996-11-07 | 1999-02-23 | Chim; Nicholas | Method for transmyocardial revascularization |
US5878751A (en) | 1996-03-04 | 1999-03-09 | Myocardial Stents, Inc. | Method for trans myocardial revascularization (TMR) |
US5885276A (en) | 1997-12-02 | 1999-03-23 | Galil Medical Ltd. | Method and device for transmyocardial cryo revascularization |
US5885272A (en) | 1990-10-30 | 1999-03-23 | Aita; Michael | System and method for percutaneous myocardial revascularization |
US5893848A (en) | 1996-10-24 | 1999-04-13 | Plc Medical Systems, Inc. | Gauging system for monitoring channel depth in percutaneous endocardial revascularization |
US5899874A (en) | 1992-04-30 | 1999-05-04 | Stiftelsen For Medicinsk-Teknisk Utveckling | Preparation and method for production of platelet concentrates with significantly prolonged viabilty during storage |
US5906594A (en) | 1997-01-08 | 1999-05-25 | Symbiosis Corporation | Endoscopic infusion needle having dual distal stops |
US5910150A (en) | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5916214A (en) | 1995-05-01 | 1999-06-29 | Medtronic Cardiorhythm | Dual curve ablation catheter |
US5921982A (en) | 1993-07-30 | 1999-07-13 | Lesh; Michael D. | Systems and methods for ablating body tissue |
US5925012A (en) * | 1996-12-27 | 1999-07-20 | Eclipse Surgical Technologies, Inc. | Laser assisted drug delivery |
US5928943A (en) | 1994-11-22 | 1999-07-27 | Institut Fur Pflanzengenetik Und Kulturpflanzenforschung | Embryonal cardiac muscle cells, their preparation and their use |
US5938632A (en) | 1997-03-06 | 1999-08-17 | Scimed Life Systems, Inc. | Radiofrequency transmyocardial revascularization apparatus and method |
US5941868A (en) | 1995-12-22 | 1999-08-24 | Localmed, Inc. | Localized intravascular delivery of growth factors for promotion of angiogenesis |
US5944716A (en) | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5951567A (en) | 1997-07-24 | 1999-09-14 | Cardiogenesis Corporation | Introducer for channel forming device |
US5964754A (en) | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5964757A (en) | 1997-09-05 | 1999-10-12 | Cordis Webster, Inc. | Steerable direct myocardial revascularization catheter |
US5968059A (en) | 1997-03-06 | 1999-10-19 | Scimed Life Systems, Inc. | Transmyocardial revascularization catheter and method |
US5971993A (en) | 1996-11-07 | 1999-10-26 | Myocardial Stents, Inc. | System for delivery of a trans myocardial device to a heart wall |
US5980548A (en) * | 1997-10-29 | 1999-11-09 | Kensey Nash Corporation | Transmyocardial revascularization system |
US6045565A (en) | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6045530A (en) | 1998-10-14 | 2000-04-04 | Heyer-Schulte Neurocare Inc. | Adjustable angle catheter |
US6051008A (en) | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
US6056760A (en) * | 1997-01-30 | 2000-05-02 | Nissho Corporation | Device for intracardiac suture |
US6056743A (en) | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US6066126A (en) | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6102887A (en) | 1998-08-11 | 2000-08-15 | Biocardia, Inc. | Catheter drug delivery system and method for use |
US6106520A (en) | 1997-09-30 | 2000-08-22 | Hearten Medical, Inc. | Endocardial device for producing reversible damage to heart tissue |
US6165164A (en) | 1999-03-29 | 2000-12-26 | Cordis Corporation | Catheter for injecting therapeutic and diagnostic agents |
US6179809B1 (en) | 1997-09-24 | 2001-01-30 | Eclipse Surgical Technologies, Inc. | Drug delivery catheter with tip alignment |
US6197324B1 (en) * | 1997-12-18 | 2001-03-06 | C. R. Bard, Inc. | System and methods for local delivery of an agent |
US6224584B1 (en) | 1997-01-14 | 2001-05-01 | Eclipse Surgical Technologies, Inc. | Therapeutic and diagnostic agent delivery |
US6238389B1 (en) | 1997-09-30 | 2001-05-29 | Boston Scientific Corporation | Deflectable interstitial ablation device |
US6251104B1 (en) | 1995-05-10 | 2001-06-26 | Eclipse Surgical Technologies, Inc. | Guiding catheter system for ablating heart tissue |
US6270496B1 (en) | 1998-05-05 | 2001-08-07 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US6309370B1 (en) | 1998-02-05 | 2001-10-30 | Biosense, Inc. | Intracardiac drug delivery |
US6322548B1 (en) | 1995-05-10 | 2001-11-27 | Eclipse Surgical Technologies | Delivery catheter system for heart chamber |
US6589232B1 (en) | 1997-11-25 | 2003-07-08 | Richard L. Mueller | Selective treatment of endocardial/myocardial boundary |
US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US6620139B1 (en) | 1998-12-14 | 2003-09-16 | Tre Esse Progettazione Biomedica S.R.L. | Catheter system for performing intramyocardiac therapeutic treatment |
US6638233B2 (en) | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US20040010231A1 (en) | 2000-07-13 | 2004-01-15 | Leonhardt Howard J | Deployment system for myocardial cellular material |
US6905476B2 (en) | 1998-06-04 | 2005-06-14 | Biosense Webster, Inc. | Catheter with injection needle |
US7094201B1 (en) | 1996-07-17 | 2006-08-22 | Medtronic, Inc. | System and method for genetically treating cardiac conduction disturbances |
-
1999
- 1999-03-17 US US09/271,094 patent/US6120520A/en not_active Ceased
-
2000
- 2000-03-17 WO PCT/US2000/007080 patent/WO2000054660A1/en active Search and Examination
- 2000-03-17 AU AU38933/00A patent/AU3893300A/en not_active Abandoned
-
2002
- 2002-09-17 US US10/246,030 patent/USRE42959E1/en not_active Expired - Lifetime
Patent Citations (231)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2749909A (en) | 1956-06-12 | Biopsy knife | ||
US1162901A (en) | 1915-10-08 | 1915-12-07 | Edward B Cantey | Instrument for cutting cores from solid substances. |
US2710000A (en) | 1952-02-19 | 1955-06-07 | Cromer Jeremiah Keith | Cutting instrument |
US3120845A (en) | 1961-02-20 | 1964-02-11 | David B Horner | Self-powered surgical drill |
US3470876A (en) | 1966-09-28 | 1969-10-07 | John Barchilon | Dirigible catheter |
US3477423A (en) | 1967-01-09 | 1969-11-11 | Baxter Laboratories Inc | Biopsy instrument |
US3614953A (en) | 1968-01-30 | 1971-10-26 | Nat Res Dev | Drills for clearing obstructions in arteries |
US3557794A (en) | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US3692020A (en) | 1971-04-29 | 1972-09-19 | Robert J Schied | Rotary punch for excising uniform diopsy specimens |
US3780246A (en) | 1972-08-22 | 1973-12-18 | Black & Decker Mfg Co | Hand-operated tool with switch actuator having three-position lock-off assembly |
US4207874A (en) | 1978-03-27 | 1980-06-17 | Choy Daniel S J | Laser tunnelling device |
US4381037A (en) | 1979-10-29 | 1983-04-26 | Black & Decker Inc. | Portable electric tool |
US4362161A (en) | 1980-10-27 | 1982-12-07 | Codman & Shurtleff, Inc. | Cranial drill |
US4461305A (en) | 1981-09-04 | 1984-07-24 | Cibley Leonard J | Automated biopsy device |
US4479896A (en) | 1981-12-11 | 1984-10-30 | Antoniades Harry N | Method for extraction localization and direct recovery of platelet derived growth factor |
US4468224A (en) | 1982-01-28 | 1984-08-28 | Advanced Cardiovascular Systems, Inc. | System and method for catheter placement in blood vessels of a human patient |
US4576162A (en) | 1983-03-30 | 1986-03-18 | Mccorkle Charles E | Apparatus and method for separation of scar tissue in venous pathway |
US4582056A (en) | 1983-03-30 | 1986-04-15 | Mccorkle Jr Charles E | Endocardial lead extraction apparatus and method |
US4640296A (en) | 1983-11-12 | 1987-02-03 | Schnepp Pesch Wolfram | Biopsy cannula |
US4600014A (en) | 1984-02-10 | 1986-07-15 | Dan Beraha | Transrectal prostate biopsy device and method |
US5443443A (en) | 1984-05-14 | 1995-08-22 | Surgical Systems & Instruments, Inc. | Atherectomy system |
US5135531A (en) | 1984-05-14 | 1992-08-04 | Surgical Systems & Instruments, Inc. | Guided atherectomy system |
USRE33258E (en) | 1984-07-23 | 1990-07-10 | Surgical Dynamics Inc. | Irrigating, cutting and aspirating system for percutaneous surgery |
US4578057A (en) | 1984-08-31 | 1986-03-25 | Cordis Corporation | Ventricular right angle connector and system |
WO1986003122A1 (en) | 1984-11-29 | 1986-06-05 | Curatech, Inc. | Wound healing agents |
US4957742A (en) | 1984-11-29 | 1990-09-18 | Regents Of The University Of Minnesota | Method for promoting hair growth |
US4856529A (en) | 1985-05-24 | 1989-08-15 | Cardiometrics, Inc. | Ultrasonic pulmonary artery catheter and method |
US4702261A (en) | 1985-07-03 | 1987-10-27 | Sherwood Medical Company | Biopsy device and method |
US4790812A (en) | 1985-11-15 | 1988-12-13 | Hawkins Jr Irvin F | Apparatus and method for removing a target object from a body passsageway |
US4646738A (en) | 1985-12-05 | 1987-03-03 | Concept, Inc. | Rotary surgical tool |
US5313949A (en) | 1986-02-28 | 1994-05-24 | Cardiovascular Imaging Systems Incorporated | Method and apparatus for intravascular two-dimensional ultrasonography |
US4729763A (en) | 1986-06-06 | 1988-03-08 | Henrie Rodney A | Catheter for removing occlusive material |
US4792327A (en) | 1986-09-15 | 1988-12-20 | Barry Swartz | Lipectomy cannula |
US4976710A (en) | 1987-01-28 | 1990-12-11 | Mackin Robert A | Working well balloon method |
US4923462A (en) | 1987-03-17 | 1990-05-08 | Cordis Corporation | Catheter system having a small diameter rotatable drive member |
US4850354A (en) | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4813930A (en) | 1987-10-13 | 1989-03-21 | Dimed, Inc. | Angioplasty guiding catheters and methods for performing angioplasty |
US4788975A (en) | 1987-11-05 | 1988-12-06 | Medilase, Inc. | Control system and method for improved laser angioplasty |
US4788975B1 (en) | 1987-11-05 | 1999-03-02 | Trimedyne Inc | Control system and method for improved laser angioplasty |
US4895166A (en) | 1987-11-23 | 1990-01-23 | Interventional Technologies, Inc. | Rotatable cutter for the lumen of a blood vesel |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US5123904A (en) | 1988-04-28 | 1992-06-23 | Olympus Optical Co., Ltd. | Surgical resecting instrument |
US5195988A (en) | 1988-05-26 | 1993-03-23 | Haaga John R | Medical needle with removable sheath |
US4917102A (en) | 1988-09-14 | 1990-04-17 | Advanced Cardiovascular Systems, Inc. | Guidewire assembly with steerable adjustable tip |
US4898577A (en) | 1988-09-28 | 1990-02-06 | Advanced Cardiovascular Systems, Inc. | Guiding cathether with controllable distal tip |
US4964854A (en) | 1989-01-23 | 1990-10-23 | Luther Medical Products, Inc. | Intravascular catheter assembly incorporating needle tip shielding cap |
US5087265A (en) | 1989-02-17 | 1992-02-11 | American Biomed, Inc. | Distal atherectomy catheter |
US5104393A (en) | 1989-08-30 | 1992-04-14 | Angelase, Inc. | Catheter |
US5106386A (en) | 1989-08-30 | 1992-04-21 | Angelase, Inc. | Catheter |
US4985028A (en) | 1989-08-30 | 1991-01-15 | Angeion Corporation | Catheter |
US5403334A (en) | 1989-09-12 | 1995-04-04 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5030201A (en) | 1989-11-24 | 1991-07-09 | Aubrey Palestrant | Expandable atherectomy catheter device |
US5152744A (en) | 1990-02-07 | 1992-10-06 | Smith & Nephew Dyonics | Surgical instrument |
US5133713A (en) | 1990-03-27 | 1992-07-28 | Huang Jong Khing | Apparatus of a spinning type of resectoscope for prostatectomy |
US5269785A (en) | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
US5125924A (en) | 1990-09-24 | 1992-06-30 | Laser Engineering, Inc. | Heart-synchronized vacuum-assisted pulsed laser system and method |
US5125926A (en) | 1990-09-24 | 1992-06-30 | Laser Engineering, Inc. | Heart-synchronized pulsed laser system |
US5242460A (en) | 1990-10-25 | 1993-09-07 | Devices For Vascular Intervention, Inc. | Atherectomy catheter having axially-disposed cutting edge |
US5505725A (en) | 1990-10-30 | 1996-04-09 | Cardiogenesis Corporation | Shapeable optical fiber apparatus |
US5093877A (en) | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5885272A (en) | 1990-10-30 | 1999-03-23 | Aita; Michael | System and method for percutaneous myocardial revascularization |
WO1992010142A1 (en) | 1990-12-10 | 1992-06-25 | Howmedica Inc. | A device and method for interstitial laser energy delivery |
US5554152A (en) | 1990-12-18 | 1996-09-10 | Cardiogenesis Corporation | Method for intra-operative myocardial revascularization |
US5380316A (en) | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5389096A (en) | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
US5224951A (en) | 1991-02-19 | 1993-07-06 | Dexide, Inc. | Surgical trocar and spike assembly |
US5339799A (en) | 1991-04-23 | 1994-08-23 | Olympus Optical Co., Ltd. | Medical system for reproducing a state of contact of the treatment section in the operation unit |
US5607421A (en) | 1991-05-01 | 1997-03-04 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5197968A (en) | 1991-08-14 | 1993-03-30 | Mectra Labs, Inc. | Disposable tissue retrieval assembly |
US5285795A (en) | 1991-09-12 | 1994-02-15 | Surgical Dynamics, Inc. | Percutaneous discectomy system having a bendable discectomy probe and a steerable cannula |
US5263959A (en) | 1991-10-21 | 1993-11-23 | Cathco, Inc. | Dottering auger catheter system and method |
US5497784A (en) | 1991-11-18 | 1996-03-12 | Intelliwire, Inc. | Flexible elongate device having steerable distal extremity |
US5358472A (en) | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Guidewire atherectomy catheter and method of using the same |
US5358485A (en) | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5396897A (en) | 1992-01-16 | 1995-03-14 | The General Hospital Corporation | Method for locating tumors prior to needle biopsy |
US5323781A (en) | 1992-01-31 | 1994-06-28 | Duke University | Methods for the diagnosis and ablation treatment of ventricular tachycardia |
US5342300A (en) | 1992-03-13 | 1994-08-30 | Stefanadis Christodoulos I | Steerable stent catheter |
US5899874A (en) | 1992-04-30 | 1999-05-04 | Stiftelsen For Medicinsk-Teknisk Utveckling | Preparation and method for production of platelet concentrates with significantly prolonged viabilty during storage |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5613972A (en) | 1992-07-15 | 1997-03-25 | The University Of Miami | Surgical cutting heads with curled cutting wings |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5366490A (en) | 1992-08-12 | 1994-11-22 | Vidamed, Inc. | Medical probe device and method |
US5342393A (en) | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
US5531780A (en) | 1992-09-03 | 1996-07-02 | Pacesetter, Inc. | Implantable stimulation lead having an advanceable therapeutic drug delivery system |
US5833715A (en) | 1992-09-03 | 1998-11-10 | Pacesetter, Inc. | Implantable stimulation lead having an advanceable therapeutic drug delivery system |
US5601586A (en) | 1992-09-30 | 1997-02-11 | Linvatec Corporation | Variable angle rotating shaver |
US5429144A (en) | 1992-10-30 | 1995-07-04 | Wilk; Peter J. | Coronary artery by-pass method |
US5287861A (en) | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5488958A (en) | 1992-11-09 | 1996-02-06 | Vance Products Incorporated | Surgical cutting instrument for coring tissue affixed thereto |
US5527279A (en) | 1992-12-01 | 1996-06-18 | Cardiac Pathways Corporation | Control mechanism and system and method for steering distal extremity of a flexible elongate member |
US5330466A (en) | 1992-12-01 | 1994-07-19 | Cardiac Pathways Corporation | Control mechanism and system and method for steering distal extremity of a flexible elongate member |
US5389073A (en) | 1992-12-01 | 1995-02-14 | Cardiac Pathways Corporation | Steerable catheter with adjustable bend location |
US5584842A (en) | 1992-12-02 | 1996-12-17 | Intramed Laboratories, Inc. | Valvulotome and method of using |
US5383884A (en) | 1992-12-04 | 1995-01-24 | American Biomed, Inc. | Spinal disc surgical instrument |
US5292309A (en) | 1993-01-22 | 1994-03-08 | Schneider (Usa) Inc. | Surgical depth measuring instrument and method |
US5273051A (en) | 1993-03-16 | 1993-12-28 | Wilk Peter J | Method and associated device for obtaining a biopsy of tissues of an internal organ |
US5354310A (en) | 1993-03-22 | 1994-10-11 | Cordis Corporation | Expandable temporary graft |
US5520634A (en) | 1993-04-23 | 1996-05-28 | Ethicon, Inc. | Mechanical morcellator |
US5507802A (en) | 1993-06-02 | 1996-04-16 | Cardiac Pathways Corporation | Method of mapping and/or ablation using a catheter having a tip with fixation means |
US5575772A (en) | 1993-07-01 | 1996-11-19 | Boston Scientific Corporation | Albation catheters |
US5669920A (en) | 1993-07-09 | 1997-09-23 | Devices For Vascular Intervention, Inc. | Atherectomy catheter |
US5921982A (en) | 1993-07-30 | 1999-07-13 | Lesh; Michael D. | Systems and methods for ablating body tissue |
US5392917A (en) | 1993-08-03 | 1995-02-28 | Ethicon, Inc. | Easy open 1-2-3 instrumentation package |
US5336237A (en) | 1993-08-25 | 1994-08-09 | Devices For Vascular Intervention, Inc. | Removal of tissue from within a body cavity |
US5425376A (en) | 1993-09-08 | 1995-06-20 | Sofamor Danek Properties, Inc. | Method and apparatus for obtaining a biopsy sample |
US5409000A (en) | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5379772A (en) | 1993-09-14 | 1995-01-10 | Intelliwire, Inc. | Flexible elongate device having forward looking ultrasonic imaging |
US5575787A (en) | 1993-09-20 | 1996-11-19 | Abela Laser Systems, Inc. | Cardiac ablation catheters and method |
US5609591A (en) | 1993-10-05 | 1997-03-11 | S.L.T. Japan Co., Ltd. | Laser balloon catheter apparatus |
US5439474A (en) | 1993-10-08 | 1995-08-08 | Li Medical Technologies, Inc. | Morcellator system |
US5456689A (en) | 1993-10-13 | 1995-10-10 | Arnold J. Kresch | Method and device for tissue resection |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5814028A (en) | 1993-11-03 | 1998-09-29 | Daig Corporation | Curved guiding introducers for cardiac access |
US5366468A (en) | 1993-11-09 | 1994-11-22 | Linvatec Corporation | Double bladed surgical router having aspiration ports within flutes |
US5492119A (en) | 1993-12-22 | 1996-02-20 | Heart Rhythm Technologies, Inc. | Catheter tip stabilizing apparatus |
US5601573A (en) | 1994-03-02 | 1997-02-11 | Ethicon Endo-Surgery, Inc. | Sterile occlusion fasteners and instruments and method for their placement |
US5419777A (en) | 1994-03-10 | 1995-05-30 | Bavaria Medizin Technologie Gmbh | Catheter for injecting a fluid or medicine |
US5776092A (en) | 1994-03-23 | 1998-07-07 | Erbe Elektromedizin Gmbh | Multifunctional surgical instrument |
US5464395A (en) | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5578067A (en) | 1994-04-14 | 1996-11-26 | Pacesetter Ab | Medical electrode system having a sleeve body and control element therefor for selectively positioning an exposed conductor area |
US5743870A (en) | 1994-05-09 | 1998-04-28 | Somnus Medical Technologies, Inc. | Ablation apparatus and system for removal of soft palate tissue |
US5683362A (en) | 1994-05-13 | 1997-11-04 | Rowland; Christopher A. | Apparatus for performing diagnostic and therapeutic modalities in the biliary tree |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5593405A (en) | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5569284A (en) | 1994-09-23 | 1996-10-29 | United States Surgical Corporation | Morcellator |
US5601588A (en) | 1994-09-29 | 1997-02-11 | Olympus Optical Co., Ltd. | Endoscopic puncture needle |
US5562694A (en) | 1994-10-11 | 1996-10-08 | Lasersurge, Inc. | Morcellator |
US5807401A (en) | 1994-11-07 | 1998-09-15 | Grieshaber & Co. Ag Schaffhausen | Ophthalmic surgical apparatus for pulverizing and removing the lens nucleus from the eye of a living being |
US5591159A (en) | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5928943A (en) | 1994-11-22 | 1999-07-27 | Institut Fur Pflanzengenetik Und Kulturpflanzenforschung | Embryonal cardiac muscle cells, their preparation and their use |
US5611803A (en) | 1994-12-22 | 1997-03-18 | Urohealth Systems, Inc. | Tissue segmentation device |
US5665062A (en) | 1995-01-23 | 1997-09-09 | Houser; Russell A. | Atherectomy catheter and RF cutting method |
US5575293A (en) | 1995-02-06 | 1996-11-19 | Promex, Inc. | Apparatus for collecting and staging tissue |
US5551427A (en) | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
US5640955A (en) | 1995-02-14 | 1997-06-24 | Daig Corporation | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
WO1996025097A1 (en) | 1995-02-17 | 1996-08-22 | Ep Technologies, Inc. | Systems and methods for examining heart tissue |
WO1996026675A1 (en) | 1995-02-28 | 1996-09-06 | Boston Scientific Corporation | Deflectable catheter for ablating cardiac tissue |
US5569254A (en) | 1995-04-12 | 1996-10-29 | Midas Rex Pneumatic Tools, Inc. | Surgical resection tool having an irrigation, lighting, suction and vision attachment |
US5651781A (en) | 1995-04-20 | 1997-07-29 | Grace-Wells Technology Partners No. 1, L.P. | Surgical cutting instrument |
US5916214A (en) | 1995-05-01 | 1999-06-29 | Medtronic Cardiorhythm | Dual curve ablation catheter |
US5606974A (en) | 1995-05-02 | 1997-03-04 | Heart Rhythm Technologies, Inc. | Catheter having ultrasonic device |
US6322548B1 (en) | 1995-05-10 | 2001-11-27 | Eclipse Surgical Technologies | Delivery catheter system for heart chamber |
US6251104B1 (en) | 1995-05-10 | 2001-06-26 | Eclipse Surgical Technologies, Inc. | Guiding catheter system for ablating heart tissue |
WO1996035469A1 (en) | 1995-05-10 | 1996-11-14 | Cardiogenesis Corporation | System for treating or diagnosing heart tissue |
US5658263A (en) | 1995-05-18 | 1997-08-19 | Cordis Corporation | Multisegmented guiding catheter for use in medical catheter systems |
US5643253A (en) | 1995-06-06 | 1997-07-01 | Rare Earth Medical, Inc. | Phototherapy apparatus with integral stopper device |
US5797870A (en) | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5840059A (en) | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
US5609621A (en) | 1995-08-04 | 1997-03-11 | Medtronic, Inc. | Right ventricular outflow tract defibrillation lead |
WO1997010753A1 (en) | 1995-09-20 | 1997-03-27 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US5702412A (en) | 1995-10-03 | 1997-12-30 | Cedars-Sinai Medical Center | Method and devices for performing vascular anastomosis |
WO1997013471A1 (en) | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
US5830222A (en) | 1995-10-13 | 1998-11-03 | Transvascular, Inc. | Device, system and method for intersititial transvascular intervention |
US5569178A (en) | 1995-10-20 | 1996-10-29 | Henley; Julian L. | Power assisted suction lipectomy device |
US5709697A (en) | 1995-11-22 | 1998-01-20 | United States Surgical Corporation | Apparatus and method for removing tissue |
US5941868A (en) | 1995-12-22 | 1999-08-24 | Localmed, Inc. | Localized intravascular delivery of growth factors for promotion of angiogenesis |
US5688234A (en) | 1996-01-26 | 1997-11-18 | Cardiometrics Inc. | Apparatus and method for the treatment of thrombotic occlusions in vessels |
US5878751A (en) | 1996-03-04 | 1999-03-09 | Myocardial Stents, Inc. | Method for trans myocardial revascularization (TMR) |
US5834418A (en) | 1996-03-20 | 1998-11-10 | Theratechnologies, Inc. | Process for the preparation of platelet growth factors extract |
US5725521A (en) | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5782823A (en) | 1996-04-05 | 1998-07-21 | Eclipse Surgical Technologies, Inc. | Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium |
EP0807412A1 (en) | 1996-05-13 | 1997-11-19 | United States Surgical Corporation | Coring device and method |
US5980545A (en) | 1996-05-13 | 1999-11-09 | United States Surgical Corporation | Coring device and method |
US5964754A (en) | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5662124A (en) | 1996-06-19 | 1997-09-02 | Wilk Patent Development Corp. | Coronary artery by-pass method |
US5766163A (en) | 1996-07-03 | 1998-06-16 | Eclipse Surgical Technologies, Inc. | Controllable trocar for transmyocardial revascularization (TMR) via endocardium method and apparatus |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US7094201B1 (en) | 1996-07-17 | 2006-08-22 | Medtronic, Inc. | System and method for genetically treating cardiac conduction disturbances |
WO1998005307A1 (en) | 1996-08-08 | 1998-02-12 | Localmed, Inc. | Transmural drug delivery method and apparatus |
US5857995A (en) | 1996-08-15 | 1999-01-12 | Surgical Dynamics, Inc. | Multiple bladed surgical cutting device removably connected to a rotary drive element |
US5989278A (en) | 1996-09-13 | 1999-11-23 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5871495A (en) | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5755714A (en) | 1996-09-17 | 1998-05-26 | Eclipse Surgical Technologies, Inc. | Shaped catheter for transmyocardial revascularization |
WO1998017186A1 (en) | 1996-10-21 | 1998-04-30 | Plc Medical Systems, Inc. | Percutaneous transmyocardial revascularization marking system |
US6030377A (en) * | 1996-10-21 | 2000-02-29 | Plc Medical Systems, Inc. | Percutaneous transmyocardial revascularization marking system |
US5830210A (en) | 1996-10-21 | 1998-11-03 | Plc Medical Systems, Inc. | Catheter navigation apparatus |
US5893848A (en) | 1996-10-24 | 1999-04-13 | Plc Medical Systems, Inc. | Gauging system for monitoring channel depth in percutaneous endocardial revascularization |
US5873366A (en) | 1996-11-07 | 1999-02-23 | Chim; Nicholas | Method for transmyocardial revascularization |
US5971993A (en) | 1996-11-07 | 1999-10-26 | Myocardial Stents, Inc. | System for delivery of a trans myocardial device to a heart wall |
US6051008A (en) | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
US5910150A (en) | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5941893A (en) | 1996-12-02 | 1999-08-24 | Angiotrax, Inc. | Apparatus for transluminally performing surgery |
US5931848A (en) | 1996-12-02 | 1999-08-03 | Angiotrax, Inc. | Methods for transluminally performing surgery |
US5944716A (en) | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5724975A (en) | 1996-12-12 | 1998-03-10 | Plc Medical Systems, Inc. | Ultrasonic detection system for transmyocardial revascularization |
US5807384A (en) | 1996-12-20 | 1998-09-15 | Eclipse Surgical Technologies, Inc. | Transmyocardial revascularization (TMR) enhanced treatment for coronary artery disease |
US5925012A (en) * | 1996-12-27 | 1999-07-20 | Eclipse Surgical Technologies, Inc. | Laser assisted drug delivery |
EP0853921A2 (en) | 1996-12-27 | 1998-07-22 | Eclipse Surgical Technologies, Inc. | Laser assisted drug delivery |
US5906594A (en) | 1997-01-08 | 1999-05-25 | Symbiosis Corporation | Endoscopic infusion needle having dual distal stops |
US6224584B1 (en) | 1997-01-14 | 2001-05-01 | Eclipse Surgical Technologies, Inc. | Therapeutic and diagnostic agent delivery |
US6056760A (en) * | 1997-01-30 | 2000-05-02 | Nissho Corporation | Device for intracardiac suture |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
US5846225A (en) | 1997-02-19 | 1998-12-08 | Cornell Research Foundation, Inc. | Gene transfer therapy delivery device and method |
US5968059A (en) | 1997-03-06 | 1999-10-19 | Scimed Life Systems, Inc. | Transmyocardial revascularization catheter and method |
US5938632A (en) | 1997-03-06 | 1999-08-17 | Scimed Life Systems, Inc. | Radiofrequency transmyocardial revascularization apparatus and method |
US6036677A (en) | 1997-03-07 | 2000-03-14 | Cardiogenesis Corporation | Catheter with flexible intermediate section |
US6093177A (en) | 1997-03-07 | 2000-07-25 | Cardiogenesis Corporation | Catheter with flexible intermediate section |
WO1998038916A1 (en) | 1997-03-07 | 1998-09-11 | Cardiogenesis Corporation | Apparatus and method of myocardial revascularization using ultrasonic pulse-echo distance ranging |
WO1998039045A1 (en) | 1997-03-07 | 1998-09-11 | Cardiogenesis Corporation | Catheter with three sections of different flexibilities |
EP0868923A2 (en) | 1997-04-04 | 1998-10-07 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US5876373A (en) | 1997-04-04 | 1999-03-02 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US6126654A (en) | 1997-04-04 | 2000-10-03 | Eclipse Surgical Technologies, Inc. | Method of forming revascularization channels in myocardium using a steerable catheter |
EP0876796A2 (en) | 1997-05-07 | 1998-11-11 | Eclipse Surgical Technologies, Inc. | Device for use in the treatment of cardiovascular or other tissue |
US5951567A (en) | 1997-07-24 | 1999-09-14 | Cardiogenesis Corporation | Introducer for channel forming device |
EP0895752A1 (en) | 1997-08-08 | 1999-02-10 | Eclipse Surgical Technologies, Inc. | Apparatus for sampling heart tissue and/or myocardial revascularization by mechanical cutting |
US5964757A (en) | 1997-09-05 | 1999-10-12 | Cordis Webster, Inc. | Steerable direct myocardial revascularization catheter |
US6179809B1 (en) | 1997-09-24 | 2001-01-30 | Eclipse Surgical Technologies, Inc. | Drug delivery catheter with tip alignment |
US6106520A (en) | 1997-09-30 | 2000-08-22 | Hearten Medical, Inc. | Endocardial device for producing reversible damage to heart tissue |
US6238389B1 (en) | 1997-09-30 | 2001-05-29 | Boston Scientific Corporation | Deflectable interstitial ablation device |
US5980548A (en) * | 1997-10-29 | 1999-11-09 | Kensey Nash Corporation | Transmyocardial revascularization system |
US6045565A (en) | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6056743A (en) | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US5851171A (en) | 1997-11-04 | 1998-12-22 | Advanced Cardiovascular Systems, Inc. | Catheter assembly for centering a radiation source within a body lumen |
US6589232B1 (en) | 1997-11-25 | 2003-07-08 | Richard L. Mueller | Selective treatment of endocardial/myocardial boundary |
US5885276A (en) | 1997-12-02 | 1999-03-23 | Galil Medical Ltd. | Method and device for transmyocardial cryo revascularization |
US6066126A (en) | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6197324B1 (en) * | 1997-12-18 | 2001-03-06 | C. R. Bard, Inc. | System and methods for local delivery of an agent |
US6309370B1 (en) | 1998-02-05 | 2001-10-30 | Biosense, Inc. | Intracardiac drug delivery |
US6270496B1 (en) | 1998-05-05 | 2001-08-07 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US6905476B2 (en) | 1998-06-04 | 2005-06-14 | Biosense Webster, Inc. | Catheter with injection needle |
US6102887A (en) | 1998-08-11 | 2000-08-15 | Biocardia, Inc. | Catheter drug delivery system and method for use |
US6045530A (en) | 1998-10-14 | 2000-04-04 | Heyer-Schulte Neurocare Inc. | Adjustable angle catheter |
US6620139B1 (en) | 1998-12-14 | 2003-09-16 | Tre Esse Progettazione Biomedica S.R.L. | Catheter system for performing intramyocardiac therapeutic treatment |
US6165164A (en) | 1999-03-29 | 2000-12-26 | Cordis Corporation | Catheter for injecting therapeutic and diagnostic agents |
US6638233B2 (en) | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US20040010231A1 (en) | 2000-07-13 | 2004-01-15 | Leonhardt Howard J | Deployment system for myocardial cellular material |
Non-Patent Citations (41)
Title |
---|
A Collection of Abstracts, Society of Thoracic Surgeons, 1999. |
Assmus, Tranplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI), Clinical Investigation and Reports, Oct. 8, 2002, pp. 3009-3017, Department of Molecular Cardiology and Department of Hematology (H.M., D.H.) University of Frankfurt, Frankfurt, Germany, Circulation availabe at http://www.circulationha.org DOI: 10.1161/01. CIR.0000043246.74879CD. |
Cooley, Denton A., M.D. et al., "Transmyocardial Laser Revascularization: Anatomic Evidence of Long-Term Channel Patency," Texas heart Institute Journal, vol. 21, No. 3 (1994), pp. 220-224. |
Cooley, Denton A., M.D. et al., "Transmyocardial Laser Revascularization: Clinical Experience with Twelve-Month Follow-Up," The Journal of Thoracic and Cardiovascular Surgery, (Apr. 1996), pp. 791-799. |
Fenton II, John W. et al., "Thrombin and Antithrombotics," Seminars in Thrombosis and Hemostasis, vol. 24, No. 2, 1998, pp. 87-91. |
Folkman, Judah, "Angiogenic Therapy of the Human Heart," Circulation, 1998; 97:628-629. |
Frazier, O.H., M.D., et al., "Myocardial Revascularization With Laser: Preliminary Findings," Supplement II Circulation, vol. 92, No. 9, (Nov. 1995), pp. II-58-II-65. |
Hardy, Roger Ian, et al., "A Histologic Study of Laser-Induced Transmyocardial Channels," Lasers in Surgery and Medicine, (1987), pp. 6:563-573. |
Henry, Timothy D., "Can We really Grow New Blood Vessels," The Lancet, vol. 351, Jun. 20, 1998, pp. 1826-1827. |
Hershey, John E. et al., "Transmyocardial Puncture Revascularization: A Possible Emergency Adjunct to Arterial Implant Surgery," Geriatrics, (Mar. 1969), pp. 101-108. |
Horvath, Keith A., M.D., et al., "Transmyocardial Laser Revascularization: Operative Techniques and Clinical Results at Two Years," The Journal of Thoracic and Cardiovascular Surgery, (May 1996) pp. 1047-1053. |
Horvath; Keith A., M.D., et al., "Recovery and Viability of an Acute Myocardial Infarct After Transmyocardial Laser Revascularization," Journal of American College of Cardiology, vol. 25, No. 1 (Jan. 1995), pp. 258-263. |
Khazei, Hassan A., et al., "Myocardial Canalization: A New Method of Myocardial Revasularization," The Annals of Thoracic Surgery, vol. 6, No. 2, (Aug. 1968) pp. 163-171. |
Knighton, David R. et al., "Role of Platelets and Fibrin in the Healing Sequence," Annals of Surgery, vol. 196, No. 4, Oct. 1982, pp. 379-388. |
Kohmoto, Takushi, M.D., et al., "Does Blood Flow Through Holmium: YAG Transmyocardial Laser Channels?," Ann. Thorac. Surg., (1996) pp. 61: 861-868. |
Kuzela, Ladislaw, et al., "Experimental Evaluation of Direct Transventricular Revascularization," Journal ofThoracic and Cardiovasuclar Surger, vol. 57, No. 6, (Jun. 1969), pp. 770-773. |
Lee, Garrett, M.D., "Effects of Laser Irradiation Delivered by Flexible Fiberoptic System on the Left Ventricular Internal Myocardium," American Heart Journal, (Sep. 1983), pp. 587-590. |
Losordo, Douglas W. et al., "Gene Therapy for Myocardial Angiogenesis Initial Clinical Results With Direct Myocardial Injection of phVEGF.sub.165 as Sole Therapy for Myocardial Ischemia," Circulation, 1998; 98: 2800-2804. |
Maloney, James P. et al., "In Vitro Release of Vascular Endothelial Growth Factor During Platelet Aggregation," American Physiological Society, H1054-H1061, 1998. |
Mandrusov, Membrane-Based Cell Affinity Chromatography to Retrieve Viable Cells, Biotechnol, Prob. 1995, 11, 208-213, Artificial Organs Research Laboratory, Department of Chemical Engineering, Material Sciences and Metallurgy, Columbia University, New York, New York 10027, and Lousville, Lousville, Kentucky 40292. |
Miyazono, Kohei et al., "Platelet-Derived Endothelial Cell Growth Factor," Progress in Growth Factor Research, vol. 3, 1991, pp. 207-217. |
NASA's Jet Propulsion Laboratory, "Swivel-head Sampling Drill Bit," NASA Tech Briefs, Nov. 1998. |
PCT Communication-Supplementary European Search Report, Aug. 3, 2001, 3 pages. |
PCT International Search Report Mar. 18, 1998, 4 pages. |
PCT Notification of Transmittal of International Preliminary Examination Report, Apr. 15, 1999, 13 pages. |
PCT Written Opinion, Dec. 23, 1998, 4 pages. |
Pipili-Synetos, E. et al., "Evidence That Platelets Promote Tube Formation By Endothelial Cells on Matrigel," British Journal of Pharmacology, vol. 125, 1998, pp. 1252-1257. |
PMR Poduct, Axcis(TM) PMR. System, http://www.cardiogenesis.com/percutaneous/product.html, Jan. 27, 1999. |
PMR Poduct, Axcis™ PMR. System, http://www.cardiogenesis.com/percutaneous/product.html, Jan. 27, 1999. |
Sen, P.K. et al., "Further Studies in Multiple Transmyocardial Acupuncture as a Method of Myocardial Revascularization," Surgery, vol. 64, No. 5, (Nov. 1968), pp. 861-870. |
Simons, Michael et al., "Food for Starving Hearts," Nature Medicine, vol. 2, No. 5, May 1996, pp. 519-520. |
Thaning, Otto, "Transmyocardial Laser Revascularisation in South Africa," SAMJ, vol. 85, No. 8 (Aug. 1995) pp. 787-788. |
The PMR(TM) Procedure, http://www.cardiogenesis.com/percutaneous/procedure.html, Jan. 27, 1999. |
The PMR™ Procedure, http://www.cardiogenesis.com/percutaneous/procedure.html, Jan. 27, 1999. |
Tsopanoglou, Nikos E. et al., "Thrombin Promotes Angiogenesis By a Mechanism Independent of Fibrin Formation," American Physiological Society, 0363-6143/93, C1302-1307. |
Verheul, Henk M.W. et al., "Platelet: Transporter of Vascular Endothelial Growth Factor," Clinical Cancer Research, vol. 3, Dec. 1997, pp. 2187-2190. |
Von Oppell, Ulrich O., "Transmyocardial Laser Revascularisation," SAMJ, vol. 85, No. 9, (Sep. 1995), p. 930. |
Wakabayashi, Akio, "Myocardial Boring For the Ischemic Heart," Arch. Surgery, vol. 95, (Nov. 1967), pp. 743-752. |
Wartiovaara, Ulla et al., "Peripheral Blood Platelets Express VEGF-C and VEGF Which Are Released During Platelet Activation," Thromb Haemost, 1998, 80:171-5. |
Washington Adventist Hospital, "Washington Area Cardiologist Performs First State-of-the-Art Heart Procedure In U.S.," PR Newswire, Dec. 15, 1999, 2 pages. |
White, Manuel et al., "Multiple Transmyocardial Puncture Revascularization in Refractory Ventricular Fibrillation due to Myocardial Ischemia," The Annals of Thoracic Surgery, vol. 6, No. 6, (Dec. 1968), pp. 557-563. |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9801650B2 (en) | 2006-12-22 | 2017-10-31 | The Spectranetics Corporation | Tissue separating systems and methods |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US10869687B2 (en) | 2006-12-22 | 2020-12-22 | Spectranetics Llc | Tissue separating systems and methods |
US9289226B2 (en) | 2006-12-22 | 2016-03-22 | The Spectranetics Corporation | Retractable separating systems and methods |
US10537354B2 (en) | 2006-12-22 | 2020-01-21 | The Spectranetics Corporation | Retractable separating systems and methods |
US9808275B2 (en) | 2006-12-22 | 2017-11-07 | The Spectranetics Corporation | Retractable separating systems and methods |
US20100234873A1 (en) * | 2007-11-27 | 2010-09-16 | Yoshitaka Nagano | Drive device, and medical apparatus and training apparatus including the same |
US10531891B2 (en) | 2012-09-14 | 2020-01-14 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9949753B2 (en) | 2012-09-14 | 2018-04-24 | The Spectranetics Corporation | Tissue slitting methods and systems |
US11596435B2 (en) | 2012-09-14 | 2023-03-07 | Specrtranetics Llc | Tissue slitting methods and systems |
US9413896B2 (en) | 2012-09-14 | 2016-08-09 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9724122B2 (en) | 2012-09-14 | 2017-08-08 | The Spectranetics Corporation | Expandable lead jacket |
US9763692B2 (en) | 2012-09-14 | 2017-09-19 | The Spectranetics Corporation | Tissue slitting methods and systems |
US10368900B2 (en) | 2012-09-14 | 2019-08-06 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US10265520B2 (en) | 2013-03-13 | 2019-04-23 | The Spetranetics Corporation | Alarm for lead insulation abnormality |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US10799293B2 (en) | 2013-03-13 | 2020-10-13 | The Spectranetics Corporation | Laser ablation catheter |
US9925371B2 (en) | 2013-03-13 | 2018-03-27 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9937005B2 (en) | 2013-03-13 | 2018-04-10 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US10485613B2 (en) | 2013-03-13 | 2019-11-26 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US11925380B2 (en) | 2013-03-14 | 2024-03-12 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US10219819B2 (en) | 2013-03-15 | 2019-03-05 | The Spectranetics Corporation | Retractable blade for lead removal device |
US11160579B2 (en) | 2013-03-15 | 2021-11-02 | Spectranetics Llc | Multiple configuration surgical cutting device |
US10136913B2 (en) | 2013-03-15 | 2018-11-27 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
US10314615B2 (en) | 2013-03-15 | 2019-06-11 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9603618B2 (en) | 2013-03-15 | 2017-03-28 | The Spectranetics Corporation | Medical device for removing an implanted object |
US10052129B2 (en) | 2013-03-15 | 2018-08-21 | The Spectranetics Corporation | Medical device for removing an implanted object |
US11925334B2 (en) | 2013-03-15 | 2024-03-12 | Spectranetics Llc | Surgical instrument for removing an implanted object |
US10849603B2 (en) | 2013-03-15 | 2020-12-01 | Spectranetics Llc | Surgical instrument for removing an implanted object |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US10524817B2 (en) | 2013-03-15 | 2020-01-07 | The Spectranetics Corporation | Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
US9956399B2 (en) | 2013-03-15 | 2018-05-01 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9925366B2 (en) | 2013-03-15 | 2018-03-27 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9918737B2 (en) | 2013-03-15 | 2018-03-20 | The Spectranetics Corporation | Medical device for removing an implanted object |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
USD806245S1 (en) | 2015-02-20 | 2017-12-26 | The Spectranetics Corporation | Medical device handle |
USD854682S1 (en) | 2015-02-20 | 2019-07-23 | The Spectranetics Corporation | Medical device handle |
USD819204S1 (en) | 2015-02-20 | 2018-05-29 | The Spectranetics Corporation | Medical device handle |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
US11554251B2 (en) * | 2019-04-30 | 2023-01-17 | Boston Scientific Scimed, Inc. | Endoscopic patch applicator |
US20230181871A1 (en) * | 2019-04-30 | 2023-06-15 | Boston Scientific Scimed, Inc. | Endoscopic patch applicator |
US11890430B2 (en) * | 2019-04-30 | 2024-02-06 | Boston Scientific Scimed, Inc. | Endoscopic applicator with reagent ball cutter |
Also Published As
Publication number | Publication date |
---|---|
US6120520A (en) | 2000-09-19 |
WO2000054660A1 (en) | 2000-09-21 |
AU3893300A (en) | 2000-10-04 |
WO2000054660A9 (en) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE42959E1 (en) | Apparatus and methods for stimulating revascularization and/or tissue growth | |
US6709427B1 (en) | Systems and methods for delivering agents into targeted tissue of a living being | |
US7147633B2 (en) | Method and apparatus for treatment of atrial fibrillation | |
US6156031A (en) | Transmyocardial revascularization using radiofrequency energy | |
US6217554B1 (en) | Methods and apparatus for delivering substances into extravascular tissue | |
US6067988A (en) | Method for creation of drug delivery and/or stimulation pockets in myocardium | |
JP4774403B2 (en) | System and method for non-invasive implantation of bioactive substances | |
US6363938B2 (en) | Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth | |
AU730720B2 (en) | Transvascular TMR device and method | |
US6267757B1 (en) | Revascularization with RF ablation | |
US8012096B2 (en) | Surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue | |
US6723082B1 (en) | Delivery catheter system for heart chamber | |
CA2307113A1 (en) | Percutaneous myocardial revascularization device and method | |
CA2305333A1 (en) | Transmyocardial revascularization using radiofrequency energy | |
EP1367947B1 (en) | Apparatus for treatment of atrial fibrillation | |
WO2002024248A1 (en) | Systems and methods for delivering beneficial agents into targeted tissue of a living being | |
JP2003515383A (en) | Methods and devices for delivering drugs to tissue | |
EP1020202A2 (en) | Medical device for transmyocardial revascularization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ABBOTT CARDIOVASCULAR SYSTEMS INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED CARDIOVASCULAR SYSTEMS, INC.;REEL/FRAME:025173/0327 Effective date: 20070214 |